Register or Login To Download This Patent As A PDF
| United States Patent Application |
20060025932
|
| Kind Code
|
A1
|
|
Dadala; Vijaya Kumar
;   et al.
|
February 2, 2006
|
Novel method for chromatographic finger printing and standardization of
single medicines and formulations
Abstract
The present invention provides a method for the chromatographic
fingerprinting, chemical and therapeutic standardization, bar-coding of
the fingerprints and preparation of a data base for Enterprise Resource
Planning (ERP) and Customer Relationship Management (CRM) machines and
applications of medicines in general and traditional medicines in
particular; this invention includes a software based instrumental method
and a novel method of fingerprinting and standardization is proposed for
the above purpose and the said method for the chromatographic finger
printing which facilitates to correlate the traditional therapeutic
standardization methods with the chemical properties of the medicines and
humors and provides a rational basis to understand the methods used for
the said purpose.
| Inventors: |
Dadala; Vijaya Kumar; (Andhra Pradesh, IN)
; Raghavan; Kondapuram Vijaya; (Andhra Pradesh, IN)
|
| Correspondence Address:
|
BUTZEL LONG;DOCKETING DEPARTMENT
100 BLOOMFIELD HILLS PARKWAY
SUITE 200
BLOOMFIELD HILLS
MI
48304
US
|
| Serial No.:
|
217025 |
| Series Code:
|
11
|
| Filed:
|
August 31, 2005 |
| Current U.S. Class: |
702/19; 436/86 |
| Class at Publication: |
702/019; 436/086 |
| International Class: |
G06F 19/00 20060101 G06F019/00; G01N 33/48 20060101 G01N033/48; G01N 33/50 20060101 G01N033/50 |
Claims
1. A method for detection and identification of principles from extracts
of plants or animal, natural or synthetic sources, using chromatographic
finger printing techniques, said method comprising the steps of: i)
extracting the organic or organo-metallic molecules using a suitable
solvent; ii) subjecting the extract obtained in step (i) to the
separation analysis, using High Pressure Liquid Chromatography
techniques; iii. generating contour and 3D chromatograms of the
ingredients eluted based on the pH and polarity; iv. converting the 3-D
and contour chromatogram obtained into a colored image, analyzing the
colored image for its individual colors using the coordinates denoting
all its 3-dimensional properties of the said image by using an inbuilt
software; v. denoting the concentrations of the various constituents
eluted with time; vi. generating a chromatogram based on color analyzed,
having peaks at various retention times along with conjugative properties
of the molecules; vii. identifying the compounds in the said ingredients
by the UV-Vis absorptive properties of the various constituents in the
image; viii. identifying, determining and classifying the compounds
eluted as polar, medium polar and less or non-polar based on the polarity
and conjugative properties; ix. generating a barcode for a selected peak
using X axis as retention time, Y axis as wavelength, R as number of red
pixels, G as number of green pixels and B as number of blue pixels; and
x. generating a database of fingerprints and barcodes and identifying the
respective compounds in the samples.
2. A method as claimed in claim 1 wherein, the solvents with different
polarities are selected based on the hydrophilic and hydrophobic nature
of the sample under study, ethyl alcohol is used for standardization of
medicines.
3. A method as claimed in claim 1 wherein, the fingerprints are developed
for the same medicine extracted under different pH ranges.
4. A method as claimed in claim 1 wherein, the HPLC apparatus used is
selected from any commercially available HPLC apparatus with the P
hoto
Diode Array detector, preferably with a gradient or ternary system of
pumps.
5. A method as claimed in claim 1 wherein, the pH and polarity of the
mobile phase is controlled by varying the ratio of the mixture 0 to 100%
of an aqueous solvent, water or a buffer at a required pH by using a salt
(like Potassium Di-Hydrogen orthophosphate or Di potassium hydrogen
orthophosphate and phosphoric acid maintaining the required pH) with a
non-aqueous solvent.
6. A method as claimed in claim 1 wherein, the non-aqueous, organic and
aqueous, water or buffer at a known pH are the solvents used in step 1
(iii) and are selected based on the range of polarity.
7. A method as claimed in claim 1 wherein, converting the contour
chromatograms into a colored image comprising the conjugative and
polarity properties of the constituents of the medicine under study.
8. A method as claimed in claim 1 wherein, the therapeutic efficacy of a
medicine (single or formulated) is assessed using the quality of the
constituents present in a particular polarity and UV-Vis absorptive zone.
9. A method as claimed in claim 1 wherein, the software generates a
barcode for a selected peak or peaks or image using the X axis as
Retention Time, Y axis as Wavelength, R as number of Red Pixels, G as
number of Green Pixels and B as number of Blue Pixels as the coordinates,
provided by the software, which makes the product propriety for an
industry.
10. A method as claimed in claim 1 wherein the software used is called
Rainbow having the following features: (a) a software with a facility of
opening chromatographic fingerprint images in different Formats
(extensions) like .BMP, JPEG, TIF, GIF from the file folders and analyze
it for different colors present in the image with single pixel
sensitivity; (b) a software with a facility of display of the pixel
information in the form of 1.a graph having a scale of X (0-(min. time
scale) and Y (200-800 nm) coordinates and 2. a Pie diagram with
individual values of each peak (Automatic and Manual) in two separate
columns beside the graph; (c) software with a facility of printing all
the data generated after analysis using PRINT Icon; (d) a software with a
facility of changing the page setup for printing using PAGE SETUP Icon;
(e) a software with a facility of selecting a part of the image and
analyze using RESIZE Icon; (f) a software with a facility of opening any
number of image analysis windows for different images, and display of
status in WINDOW icon; (g) a software with a facility of dividing the
image in to three Zones at 20 min interval, using ZONE icon; (h) a
software with a facility of inverting the selected image using INVERT
icon; (i) a software with a facility of switching over to Notepad, Word
pad and MS Word, using EDITOR icon; (j) a software with a facility of
operational information about various features of the Software using, the
HELP icon; and (k) software with a facility of saving the data generated
using SAVE AS icon as. JEPG file format.
11. A software based data processing of 3 D chromatograms and color
contour image of an ingredient, said processing comprising: a. analyzing
(extracting colors) the colored contour image based on the selection of
various colors (with standards mentioned in release notes, life cycle,
processing) denoting the concentrations of the various constituents
eluted with time, and polarity based on retention time; b. analyzing the
3-D chromatograms of the medicine using all its 3 dimensional properties
of the image; c. generating a chromatogram having peaks at various
retention times along with conjugative properties of the molecules eluted
with time in a specified order of polarity; d. identifying the compounds
in the said molecules by the UV-Vis absorptive properties of the various
constituents in the image; e. correlating the reported biological,
therapeutic activity of the of various constituents present in the
medicines understudy based on the polarity and the conjugative properties
of the molecules by dividing the fingerprint into therapeutic zones on X
and Y axis; f. generating a barcode for a selected peak(s) using the
image coordinates viz., X for retention time, Y for wavelength, R for
number of red pixels, G for number of green pixels and B for number of
blue pixels, provided by the proposed software; g. generating a database
of fingerprints and barcodes for the samples, facilitating all kinds of
database utilities like Enterprise Resource Planning (ERP) and Customer
Resource Management (CRM) applications; and h. generating a database of
the `display widows` for all the samples to be used by the ENTERPRISE
RESOURCE PLANNING (ERP) and CUSTOMER RELATIONSHIP MANAGEMENT (CRM) type
of business applications.
12. A method as claimed in claim 11 wherein, the solvents used for
extraction is selected based on the polarity, hydrophilic and hydrophobic
nature of the constituents, sample and its constituents under study.
13. A method as claimed as claimed in claim 11 wherein, the HPLC apparatus
used is selected from any commercially available HPLC apparatus with the
Photo Diode Array detector, preferably with a gradient or ternary system
of pumps.
14. A method as claimed in claim 11 wherein, the polarity of the mobile
phase of a non-aqueous and an aqueous solvent of a specific pH is
controlled by varying the ratio of the mobile phase from 0% to 100% of an
aqueous solvents like water or a buffer of a known pH, along with a
non-aqueous solvent or vice-versa.
15. A method as claimed in claim 11 wherein, on analysis of 3-D and
contour chromatograms using new software called Rainbow, that gives a
chromatogram with retention time and wavelength on its X and Y-axis.
16. A method as claimed in claim 11, wherein, on analysis of 3-D and
contour chromatograms using new software which gives a data having
indicated the vitiation of doshas quantitatively in percentage ratio.
17. A method as claimed in claim 11 wherein, a single solvent ethanol is
used for extraction of the constituents; same analytical conditions and
instrumental parameters were used for all samples to bring the
therapeutic generalizations. The therapeutic standardization is thus
achieved.
18. A method as claimed in claim 11 wherein the software used is called
Rainbow having the following features: i. a software with a facility of
opening chromatographic fingerprint images in different Formats
(extensions) like .BMP, JPEG, TIF, GIF from the file folders and analyze
it for different colors present in the image with single pixel
sensitivity; ii. a software with a facility of display of the pixel
information in the form of 1.a graph having a scale of X (0-(min. time
scale) and Y (200-800 nm) coordinates and 2. a Pie diagram with
individual values of each peak (Automatic and Manual) in two separate
columns beside the graph; iii. software with a facility of printing all
the data generated after analysis using PRINT Icon; iv. a software with a
facility of changing the page setup for printing using PAGE SETUP Icon;
v. a software with a facility of selecting a part of the image and
analyze using RESIZE Icon; vi. a software with a facility of opening any
number of image analysis windows for different images, and display of
status in WINDOW icon; vii. a software with a facility of dividing the
image in to three Zones at 20 min interval, using ZONE icon; viii. a
software with a facility of inverting the selected image using INVERT
icon; ix. a software with a facility of switching over to Notepad, Word
pad and MS Word, using EDITOR icon; x. a software with a facility of
operational information about various features of the Software using, the
HELP icon; and xi. software with a facility of saving the data generated
using SAVE AS icon as. JEPG file format.
19. A computational method of chromatographic finger printing, chemical
and therapeutic standardization and bar coding of organic and
organo-metallic molecules from a plant, animal or a naturally available
or man made materials used as medicines, said method comprising a)
selection of medicines and extraction of the constituents, b) separation
of the constituents into individual constituents, generating and
converting the 3-D and contour chromatograms into fingerprints, c)
analyzing the fingerprints using the software developed, and d)
interpretation the data.
20. A method as claimed in claim 19 wherein, it provides chemical analysis
of the constituents present in the medicine under study and their
conjugative and polarity properties indicating the therapeutic efficacy
as per the traditional concepts of the medicine using the new software
developed.
21. A method as claimed in claim 19 wherein, it provides a novel concept
of chromatographic finger printing of herbal medicines which is useful
for the quick identification of the actual profile of the compounds
present in the medicine under use along with their therapeutic efficacy
of the constituents.
22. A method as claimed in claim 19 wherein, it provides a novel
chromatographic finger printing of herbal medicines and formulations
using the contour and 3-D chromatograms of the herbal medicines and
formulations is proposed and they are developed on a Photo Diode Array
Detector (PDA) of a High Pressure Liquid Chromatograph. This delineates
the data of the spectral properties of the constituents present in the
herbal medicines presented in a specific order of polarity under similar
experimental analytical conditions.
23. A method as claimed in claim 19 wherein, said method provides
UV-Visible spectra of the compounds having displayed the conjugative and
polarity properties of the molecules and the concentration of the
individual concentrations of the molecules along with the polarity of the
molecules.
24. A method as claimed in claim 19 wherein, said method provides UV-VIS
spectra of all the constituents shown in a single image "The
Chromatographic Fingerprint", the said fingerprint becomes the blue print
of the constituents present in an herbal medicine or formulation for an
assay and quick identification of the medicine understudy.
25. A method as claimed in claim 24 wherein, same standard analytical
parameters like extraction with same solvent ethyl alcohol, same run time
0-60 min, same mobile phase acetonitrile along with phosphate buffer
having a pH in the range of 5.5-7.5, and a same UV-Visible Range of
200-800 nm for fingerprinting and chemical and therapeutic
standardization.
26. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of adulterated, substituted, contradictual and commercial food
and drug samples and to identify the pure and impure.
27. A method as claimed in claim 24 wherein, fingerprinting method is used
for identifying the chemical constituents present in it for the purpose
of process standardization, quality control activities and therapeutic
standardization of Allopathic, Ayurvedic, Homoeo, Siddha, Unani, Chinese,
Tibetan, Kampo (Japanese) medicines.
28. A method as claimed in claim 24 wherein, fingerprinting method is used
for the study of variation of chemical constituents due to various
ecological factors, geological factors, genotypic and phenotypic
variations (in plants) in naturally occurring samples and to identify and
standardize the chemical constituents in them.
29. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of chemical constituents in synthetically prepared samples and
to identify and standardize the chemical constituents in them for
chemical and therapeutic standardization which ever is applicable.
30. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of chemical constituents in herbal products of single medicine
samples and to identify the chemical constituents in them for chemical
and therapeutic standardization.
31. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of chemical constituents in herbal products of formulated
medicine samples and to identify the chemical constituents in them for
chemical and therapeutic standardization.
32. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of variation of chemical constituents in biological samples and
to identify and standardize the chemical constituents in them.
33. A method as claimed in claim 24 wherein, fingerprinting is used for
the study of variation of chemical constituents in different brands of
products of single and formulated food and medicine samples and to
identify the chemical constituents in them for chemical and therapeutic
standardization.
34. A method as claimed in claim 24 wherein, preparation of a database of
a large number samples gives many generalizations of the therapeutic
efficacy of a particular group of plants, classified as a group for a
particular disease or therapeutic classification.
35. A method as claimed in claim 24 wherein, fingerprinting of medicines
facilitates to categorize and quantify the constituents of a medicine
based on polarity and conjugation from 3-D and contour chromatograms and
assess the therapeutic efficacy of the medicine on which humors it is
going to act (vitiate).
36. A method as claimed in claim 24 wherein, fingerprinting enables to
understand and standardize the Physico-Chemical properties of the
medicines like color for the use of therapeutic standardization of
medicines and humors using conjugative and polarity properties given in
the chromatographic fingerprints.
37. A method as claimed in claim 24 wherein, the fingerprinting method
enables to understand and standardize the Physico-Chemical properties of
the medicines like Tastes (Rasa) like Sour, Salty, Pungent, Bitter,
Astringent (Amla, Lavana, Katu, Tikta, Kashaya as described in Ayurveda)
used for therapeutic standardization using conjugative and polarity
properties shown in the chromatographic fingerprints.
38. A method as claimed in claim 24 wherein, the fingerprinting method
enables to understand and standardize the Physico-Chemical properties of
the medicines like Property, Potency, Metabolite, Specific properties
like Chirality of the molecules (Guna, Veerya Vipaka, Prabhava) used for
the therapeutic standardization using conjugative and polarity properties
of the individual constituents and the whole medicine shown in the
chromatographic fingerprints.
39. A method as claimed in claim 24 wherein, the fingerprinting method
enables to understand and standardize the Physico-Chemical properties
(Gunas) of the medicines like Cold, Hot, Slow in action, Sharp in action,
Heavy, Light, Soft Lubricated Supple, Dry (Sheeta, Ushna, Manda,
Teekshna, Guru, Laghu, Snigdha, Rooksha as described in Ayurveda) used
for the therapeutic standardization using conjugative and polarity
properties of the medicines shown in chromatographic fingerprints.
40. A software based data processor of 3 D chromatograms and color contour
image of an ingredient, said processor comprising computing means and
capable of: i) an analyzer (extracting colors) for analyzing the colored
contour image based on the selection of various colors (with standards
mentioned in release notes, life cycle, processing) denoting the
concentrations of the various constituents eluted with time, and polarity
based on retention time; ii) an analyzer for analyzing the 3-D
chromatograms of the medicine using all its 3 dimensional properties of
the image; iii) a means for generating a chromatogram having peaks at
various retention times along with conjugative properties of the
molecules eluted with time in a specified order of polarity; iv) an
identifier for identifying the compounds in the said molecules by the
UV-Vis absorptive properties of the various constituents in the image; v)
a means for correlating the reported biological, therapeutic activity of
the of various constituents present in the medicines understudy based on
the polarity and the conjugative properties of the molecules by dividing
the fingerprint into therapeutic zones on X and Y axis; vi) a means for
generating a barcode for a selected peak(s) using the image coordinates
viz., X for retention time, Y for wavelength, R for number of red pixels,
G for number of green pixels and B for number of blue pixels, provided by
the proposed software; vii) a means for generating a database of
fingerprints and barcodes for the samples, facilitating all kinds of
database utilities like Enterprise Resource Planning (ERP) and Customer
Resource Management (CRM) applications; and viii) a means for generating
a database of the `display widows` for all the samples to be used by the
ENTERPRISE RESOURCE PLANNING (ERP) and CUSTOMER RELATIONSHIP MANAGEMENT
(CRM) type of business applications.
41. A processor as claimed in claim 40 wherein, the solvents used for
extraction is selected based on the polarity, hydrophilic and hydrophobic
nature of the constituents, sample and its constituents under study.
42. A processor as claimed in claim 40 wherein, the HPLC apparatus used is
selected from any commercially available HPLC apparatus with the P
hoto
Diode Array detector, preferably with a gradient or ternary system of
pumps.
43. A processor as claimed in claim 40 wherein, the polarity of the mobile
phase of a non-aqueous and an aqueous solvent of a specific pH is
controlled by varying the ratio of the mobile phase from 0% to 100% of an
aqueous solvents like water or a buffer of a known pH, along with a
non-aqueous solvent or vice-versa.
44. A processor as claimed in claim 40 wherein, on analysis of 3-D and
contour chromatograms using new software entitled "Rainbow" that gives a
chromatogram with retention time and wavelength on its X and Y-axis.
45. A processor as claimed in claim 40 wherein, on analysis of 3-D and
contour chromatograms using new software which gives a data having
indicated the vitiation of doshas quantitatively in percentage ratio.
46. A processor as claimed in claim 40 wherein, a single solvent ethanol
is used for extraction of the constituents; same analytical conditions
and instrumental parameters were used for all samples to bring the
therapeutic generalizations. The therapeutic standardization is thus
achieved.
47. A processor as claimed in claim 40 wherein, the software Rainbow has
the following features: (a) It is software entitled `Rainbow`; (b) A
software with a facility of opening chromatographic fingerprint images in
different Formats (extensions) like .BMP, JPEG, TIF, GIF from the file
folders and analyze it for different colors present in the image with
single pixel sensitivity; (c) A software with a facility of display of
the pixel information in the form of 1.a graph having a scale of X
(0-(min. time scale) and Y (200-800 nm) coordinates and 2. a Pie diagram
with individual values of each peak (Automatic and Manual) in two
separate columns beside the graph; (d) Software with a facility of
printing all the data generated after analysis using PRINT Icon; (e) A
software with a facility of changing the page setup for printing using
PAGE SETUP Icon; (f) A software with a facility of selecting a part of
the image and analyze using RESIZE Icon; (g) A software with a facility
of opening any number of image analysis windows for different images, and
display of status in WINDOW icon; (h) A software with a facility of
dividing the image in to three Zones at 20 min interval, using ZONE icon;
(i) A software with a facility of inverting the selected image using
INVERT icon; (j) A software with a facility of switching over to Notepad,
Word pad and MS Word, using EDITOR icon; (k) A software with a facility
of operational information about various features of the Software using,
the HELP icon; and (l) Software with a facility of saving the data
generated using SAVE AS icon as JEPG file format.
48. Use of fingerprints of contour and 3-D chromatograms of the chemical
are the basis for identification of chemical constituents to limit the
scope of the invention.
Description
TECHNICAL FIELD
[0001] The present invention relates to a novel method of chromatographic
finger printing useful for chemical and therapeutic standardization. More
particularly, the present invention relates to chromatographic
fingerprinting of organic and organo-metallic molecules which have
UV-Visible radiation absorptive property present in a plant, animal or
any other source capable of being used as a single or formulated
medicine. The invention facilitates bar coding of one or many
constituents present in the finger print images. It also facilitate
commercial utilization of the fingerprint database having all the
information about the medicines, development and using ERP (Enterprise
Resource Planning) and CRM (Customer Relationship Management) net work
applications like vending machines etc.
[0002] The present invention employs a novel method of the utilization of
the Contour and 3D chromatograms of an herbal medicine and formulation
developed under standardized experimental (chemical and instrumental)
conditions proposed as a chromatographic finger print of the medicines.
[0003] In addition, the present invention relates to a computer-based
method for the analysis of such chromatograms. This novel method is very
much used for an authentic identification of the chemical constituents of
the single medicines and formulations.
BACKGROUND ART
History of Traditional Medicines in the World
[0004] The ancient man after many years of evolution started thinking
about him and tried to understand the nature. He started living under a
cover, the caves and in-groups. The process of thought has encouraged him
to understand the nature and its inter action with the living beings. He
started using the naturally available flora and fauna for his daily
needs, in which he used the plant and animal material for his dietary and
health needs.
[0005] Under this process, he explored the properties of various
components in the world, like geological, astral and medicinal properties
of various biological and plant materials. This started happening from
the Stone Age on words. He went on discovering, standardizing and using
naturally available materials for his day-to-day living.
[0006] This took place in many places of the earth parallel in different
parts of the world and it developed more in places where civilization has
developed more based on the intellectuality. Therefore, the history of
medicine has a direct relation with the history of civilization.
[0007] The evidences of an well-organized system of medicine in India were
traced in Harappa and Mohanzadaro (History of Medicine in India, Dr Priya
Vrit Sharma, Indian National Science Academy, New Delhi). In the Indus
valley civilization, a system of medicine has prevailed, in which drugs
of vegetable, animal and mineral origin were used. The Osadhisukta of the
Rigveda is the oldest document of the knowledge about plants and herbal
medicines. Medicine in India owes much to the traditional knowledge of
Atharvaveda of which Ayurveda is said as an Upaveda. A large number of
disease-syndrome relationships were defined and described by Charaka and
Susruta in their medical treatises `The Samhitas`. The treatment was also
prescribed in a systematic manner and on rational basis.
[0008] On the other hand, it was realized that the biological phenomena
could not be universally explained by mechanical means as each individual
varies in his basic constitution i.e., Prakruthi that must be kept in
mind while prescribing diet or drug to the patient. The binary concept
like Prakriti-Purusha, Yin-Yang, Normal-Abnormal was seen in almost all
philosophies.
[0009] Diseases are manifestations of humoral imbalance, which have to be
tackled comprehensively on the psychosomatic basis. Health accordingly is
equilibrium maintained on physical, mental and spiritual levels. Thus,
the Tri-dimensional definition of health as propounded by Susrtuta is the
ideal one, which has been reflected in the definition, adopted by WHO in
modern times.
[0010] After going through the ancient literature it was found that, the
medicines were standardized using their physico-chemical properties of
the materials. The color, texture, odor and taste were used as a measure
of the efficacy of any medicine. Even the shape of the medicines was used
to understand the medicinal properties of the medicines. A summary of
different philosophies and various factors used in the therapy is given
in Tables 1-6 which are appearing in the later part of the description.
FIG. 1 accompanying the specification gives a detailed information on the
individual philosophies and concepts of Indian Ayurveda and Chinese
Traditional medicines (Medicine in China by H. M. Sais and A hand book of
Chinese Healing Herbs by Daniel Reid, Simon & Schuster) in particular and
other philosophies in general. The therapeutic efficacy of a medicine
ultimately depends on the chemical constituents present in the medicines
under use and it is the chemical properties of the constituents that are
going to bring a required change in the chemical constitution of the
living animal.
[0011] Many Ayurvedic (one kind of Indian system of medicine) scholars
have defined and classified the medicines based on color and their
therapeutic efficacy. A brief summary is given in Table 7, which appears
in the later part of the description. Thus, the physico-chemical
properties of the materials and man is taken in to consideration to
understand the properties of them and use for the therapy to achieve
required therapeutic results. Tables 8-9 which are appearing in the later
part of the description gives the information about how the physical
properties (color) and chemical properties (taste) are used for
understanding the therapeutic efficacy of medicines and their influence
on the physiology of the human body. One part of the present work also
uses the same methodology, but with instruments.
[0012] In general, the constituent molecules present in the drugs and
foods can be broadly classified in to three categories as polar, medium
polar and the non-polar molecules. The total polarity of the molecule
depends on the total Electrophlic and Nucleophilic moieties attached to
the molecule along with the unsaturation of the molecules by their
conjugation. The living human body, animal body and plants will also
contain the same type of molecules wherein different polar molecules will
carry out different functions. Diseases were cured using the medicines of
same polarity as that of the disease causing chemical constituents, i.e.
the medicines which can create the disorder can cure the same disorder,
as said by Dr Hanemann.
WHO Definition of Herbal Medicine:
[0013] WHO has defined herbal medicine as a "Finished, labeled medicinal
products that contain as active ingredients aerial or underground parts
of plants, or other plant material, or combinations thereof whether in
the crude state or as plant preparations. Plant material includes juices,
gums, fatty oils, essential oils, and any other substances of this
nature. Herbal medicines may contain excipients in addition to the active
ingredients. Medicines containing plant material combined with chemically
defined active substances, including chemically defined, isolated
constituents of plants, is not considered to be herbal medicines.
Exceptionally, in some countries herbal medicines may also contain, by
tradition, natural organic or inorganic active ingredients which are not
of plant origin".
[0014] The objective of these guidelines, therefore, is "to define basic
criteria for the evaluation of quality, safety, and efficacy of herbal
medicines and thereby to assist national regulatory authorities,
scientific organizations, and manufacturers to undertake an assessment of
the documentation/submission/dossiers in respect of such products". As a
general rule in this assessment, traditional experience means that
long-term use as well as the medical, historical and ethnological
background of those products shall be taken into account. The definition
of long-term use may vary according to the country but should be at least
several decades. Therefore, the assessment should take into account a
description in the medical/pharmaceutical literature or similar sources,
or a documentation of knowledge on the application of an herbal medicine
without a clearly defined time limitation. Marketing authorizations of
similar products should also be taken into account. As per the report,
the assessment of quality should be done for the following parameters.
[0015] WHO guidelines were given for the finished product for which, the
assessment of efficacy, activity, evidence required to support
indications and combination products. Many herbal remedies consist of a
combination of several active ingredients, and as experience of the use
of traditional remedies is often based on combination products,
assessment should differentiate between old and new combination products.
Identical requirements for the assessment of old and new combinations
would result in inappropriate assessment of certain traditional
medicines. In the case of traditionally used combination products, the
documentation of traditional uses (such as classical texts of Ayurveda,
TraditionaL Chinese medicine, Unani and Siddha) and experience may serve
as evidence of efficacy.
[0016] An explanation of new combination of well known substances
including effective dose ranges and compatibility should be required in
addition to the documentation of traditional knowledge of each single
ingredient. Each active ingredient must contribute to the efficacy of the
medicine. Clinical studies may be required to justify the efficacy of a
new ingredient and its positive effect on the total combination.
[0017] In the report, it was also mentioned that the manufacturing
procedure and formula, including the amount of excipients, should be
described in detail. A finished product specification should be defined.
A method of identification and where possible, quantification of the
plant material in the finished product should also be defined. If the
identification of an active principle is not possible, it should be
sufficient to identify a characteristic substance or mixture of
substances (e.g., "chromatographic fingerprint") to ensure consistent
quality of the product. The finished product should comply with general
requirements for particular dosage forms.
[0018] For imported finished products, confirmation of the regulatory
status in the country of origin should be provided. The WHO Certification
Scheme on the quality of pharmaceutical products moving in international
commerce should be applied. More details about stability, assessment of
safety and utilization were given in the said WHO report.
[0019] The effective regulation of the quality of herbal medicines moving
in international commerce also requires close liaison between national
institutions that are able to keep under regular review all aspects of
production and use of herbal medicines. Also, to conduct or sponsor
evaluative studies of their efficacy, toxicity, safety, acceptability,
cost and relative value are compared with other drugs used in modern
medicine.
[0020] Hence, as mentioned above, there is a need for an authentic method
of quality control as proposed in this work. It is clearly mentioned that
there is a need of a method for all the above purposes. The proposed
analytical will give answers for almost all of the needs described above.
Existing Methods of Standardization:
[0021] Before explaining the method of the invention of standardization,
the existing methods of standardization (chemical and therapeutic) and
chromatographic finger printing are discussed below.
A. Prior Art on Chemical Standardization:
[0022] I) Traditional:
[0023] The great sage Charaka explained in his Charaka Samhita that "The
understanding of the totality of an entity does not arise from a
fragmentary knowledge of it" (Charaka Samhita VI. 4.5). This makes it
clear that standardization and therapeutic efficacy of any medicine for
which all the constituents are not taken into consideration is futile.
[0024] The qualitative and quantitative profile of a herbal medicine will
vary due to many geological, ecological factors, time of collection,
place of collection, age of collection and weather conditions at the time
of collection and so on.
[0025] Traditional herbalists used to select a medicine based on the
organoleptic methods available at that time like color, texture, smell
and taste by which they used to assess the chemical and therapeutic
efficacy of a medicine.
[0026] These methods involve intrinsic knowledge and understanding of the
inter and intra therapeutic interactions of the medicines and body
constituents to cure diseases. This knowledge varies from individual to
individual and depends on the individual skill and ability. Practically,
it will be difficult to provide a rational justification for any
mechanism to explain, using this method. Hence, modern science uses
instruments for various purposes, which eliminates the individual factors
and facilitates reproducibility in data and information.
[0027] ii) Modern:
[0028] The therapeutic property of any food or drug will depend on its
chemical and physical status. Thus, understanding the chemical
constituents using their physico-chemical properties will help to
understand the therapeutic efficacy of the medicine.
[0029] The physico chemical properties of the medicines play a major role
on the therapeutic activity of the medicine. These properties of
molecules can be studied using two parameters, the polarity and
conjugative properties. Polarity is a resultant electrochemical property
due to different electron donating (nucleophilic) and electron accepting
(electrophilic) moieties attached to the molecules along with the
unsaturated double and triple bonds present in it. They will influence
the rate of activity or reactivity of a molecule in chemical and
biochemical reactions. A thorough estimation of the total polarity of the
molecule will give the efficacy of a single or group of molecules as to
how active they are chemically and therapeutically. Hence, any
standardization, which assesses the above properties, will be useful to
know their activity.
[0030] Along with the polarity, which relates mostly to the
Electro-chemical property of the molecules the physical structure of the
molecule also play an important role in the reactivity of the molecules.
The more the number of active sites attached to the molecules, the more
reactive they will be. The more the molecule is conjugated (having
alternative double bond and triple bonds) the more it will be reactive
chemically and so therapeutically.
[0031] The second parameter that influences the activity of the molecule
is the spatial arrangement of atoms in the same molecule, which differs
structurally. Due to this reason, the isomeric (geometric and chiral)
molecules play an important role in the biological activity. This
stereo-selective nature makes the molecules highly selective in their
activity in the body where in a large number of biochemical pathways will
be working parallel without cross interactions and interferences. Hence,
the chemistry of chiral drugs has become very important. In other terms,
no key (chiral molecule) will open a different lock (receptor).
[0032] Plants usually prepare a plurality/combinatorial library of
molecules having the same basic mother structures and varying in the
functional groups attached to it. For example, flavones, aurones and
chalcones of flavoniods as they exist in nature and a single plant having
such set of molecules will act like a multi drug.
[0033] Usually molecules having unsaturation and more conjugation absorbs
the electromagnetic radiation in the UV-Visible radiation (200-800 nm).
When the compounds interact with radiation they absorb at a specific
wavelength (absorbance maxima) based on their chemical, conjugative and
structural properties. It is called the characteristic wavelength. A
molecule can have more than one-absorbance maxima based on its structural
and functional properties. When a compound absorbs a particular color
from the wholesome of the white light it will express the resultant color
of the other colors unabsorbed. Thus, the materials will express
different colors based on their chemical constituents absorbing various
colors from white light and showing that their color is due to the
various functional groups attached to it. (Table No 10, which appears
later part of the description, explains the same). The same is taken as a
measure of the chemical and physical properties of the molecules in
spectrophotometry.
[0034] For example, the red colored medicines absorbs at 500-600 nm range.
Thus, all the red colored medicines will have a peak in this wavelength
range having specific structure and activity. Hence, the color of the
medicines is being used as a measure of its therapeutic and chemical
efficacy of the medicines. In ancient times, medicines were classified
therapeutically based on the color. The present method proves the same.
The FIG. 2 which accompanying the specification depicts relation of
colors with humors shows the effect of different colors on different
diseases.
[0035] FIG. 3, which accompany the specification, the fingerprints of two
Shilajit samples prepared by the method of the invention, shows the
difference in the chemical profile of both samples. Shilajit is a
carbonaceous material that forms due to storage of vegetable and animal
matter inside the earth for many years. Mostly due to lava floated over a
forest destroying flora and fauna. This after undergoing many geological
changes becomes carbonaceous material called Shilajit. It is abundantly
available in Russia. It is the most widely used as medicine in the world.
It is observed that although the general pattern of the molecules is
found to be similar in Shilajit samples of different sources, the
variation in the conjugative properties of the molecules is found
different. This makes these medicines vary in their therapeutic efficacy
hence, this type of fingerprinting is useful.
[0036] In the modern chemical analysis methods, determination of the
percentage of active principles viz., alkaloids, flavonoids, enzymes,
vitamins, essential oils, fats, carbohydrates, proteins, ash,
acid-insoluble ash, and crude fiber is done by various analytical
instruments. Some examples shown below explain how standardization is
done in modern science.
[0037] It is reported (WWW// Shilajit, Fulvic acid etc,. html) that, one
of the very important medicines used in Indian System of medicine
Shilajit, is reported to have many compounds along with fulvic acids, and
is claimed to be active principle. As this medicine from bituminous
source is collected from earth stored for many years, it can be seen that
the more it is in stored in the earth, the more it will be
therapeutically active. Nevertheless, in the entire globe, the geological
variations may not produce same molecules in all samples collected from
different parts of the world. Another factor that influences the
chemistry of these drugs is the purification process, which also needs to
be standardized.
[0038] It is reported (WWW//Herbology. html) that, mostly standardization
is done for the individual key components, which have been empirically,
and scientifically proven to be most advantageous for the human system.
So usually, standardization is done for certain molecules out of all
present, which are found to have activity. However, the synergistic
effect of other compounds present in the medicine making the total
profile of the medicine should be taken into consideration for its
efficacy.
[0039] It is reported (WWW//Tribulus Terrestrius puncture vine. html)
that, the alcoholic extract of the fruits of Tribulus Terrestrius shows
antiurolithiatic activity. In addition to this, the extract also shows a
significant diuretic activity. The alkaloid Harman has been reported from
the herb and Harmine from the seeds. The plant contains saponins, which
on hydrolysis yield steriodal sapogenins. Many molecules of flavonoid in
nature are reported in which the active principle is found saponins. The
analytical report is given for the heavy metal analysis and total
saponins content (20% w/w)
[0040] It is reported (WWW// Charak_com.--Quality control page--html)
that, Human life is a synergy of Mental, Physical and Spiritual
components, which are related to the Indian Philosophy of Ayurveda where
Pitta, Kapha and Vata are considered as the basis for the total health of
human beings. More details of standardization are given in the
description of traditional methods of therapeutic standardization.
[0041] It is reported (WWW//Standardized Herbal Extracts\ A herbalists
Perspective's, Dr. Micheal Tierra L. Ac.O.M.D html) that, due to European
Guaranteed Potency Law, it becomes compulsory to standardize herbal
medicines. The meaning of herbal standardization is defined as
quantification of an active constituent or marker extract, where in the
activity is attributed to be the most.
[0042] It is explained (Frank R Stermitz et al, PAINS/February 15,200/Vol
97, No 4, pp 1433-1437) that, in the plant Berberis Aristata the
antimicrobial property of the extract is due to the presence of 5-Hydroxy
Hydnocarpin, the berberin acting as anti microbial, and without which it
will not. Hence, the synergistic effect of the entire constituents should
be taken into consideration while dealing with an herbal medicine but not
only an active constituent.
[0043] WHO in its Regional Publication (Dr Ranjit Roy Choudary, Hrebal
Medicine for Human Health, Searo no 20) clearly mentioned what
standardization is and what the member countries should do for the better
use of its medicines by the people.
[0044] The role of acidity and alkalinity can be understood by carefully
understanding the extraction process of constituents from the medicines
at different pH values of the extraction solvents. This helps to
understand the drug release mechanism in the intestine from the medicine
consumed by the persons having different intestinal pH. The role of
acidity and alkalinity was studied and understood carefully in
understanding the therapeutic efficacy of a medicines. Acidity and
alkalinity of organic and inorganic molecules are studied thoroughly to
know their properties as shown in Table 11 which appear later part of the
specification. Of acidity and alkalinity shows the role of acidity and
alkalinity on health (Health in Hands by Devendra Vora, Navaneet
publications (India) Ltd).
[0045] It is reported (WWW// Chewing. Html) that, in a study it was
observed that people with acidic systems absorb more pollution than
people who had established proper blood alkalinity. Acid/alkaline (pH)
balance is important for normal cell function. More details were given in
the article. Hence, the study of the acidity or alkalinity (organic or
inorganic) in terms of `polarity` will give the information of the
therapeutic efficacy of the medicines. Hence, the present method, which
can do this job, will be of much use to know the therapeutic efficacy of
the medicines. Using this proposed method, the acidity and alkalinity can
be established for the therapeutic standardization of medicines.
[0046] References made above will explain the conventional and reported
methods of standardization, wherein the individual constituents are
isolated at a preparative scale and compared qualitatively and
quantitatively with the same compound present in the sample medicine
under study.
[0047] In one of the reports (Pharmaceutical grade Saw Palmetto, Khwaja,
et al U.S. Pat. No. 6,039,950) it was reported that the different
individual fractions of ethanolic extract of Saw Palmetto were studied
for their bioactivity by measuring the determination of IC 50 in an
androgen receptor binding inhibition assay. Measurement of total fatty
acid assay of whole extract and individual fractions were discussed. The
fractions containing linolic acid ethyl ester and lauric acid ethyl ester
were identified. The activity was calculated for each of the fraction for
which androgen receptor binding inhibition has been assayed compared to
the total bioactivitty of the sample. The molecular weight and amount of
the individual fatty acids were identified and incorporated in to the
calculation of bioactivity. The total bioactivity of the extract was
calculated comparing to the total percent activity of linolic and lauric
acid ethyl ester fractions.
[0048] In the traditional medicine standardization, the total profile
should be taken into consideration for the therapeutic efficacy of the
herbal medicine. Hence, in the present computer-based instrumental
method, the total properties of all the constituents are taken into
consideration as suggested in traditional concepts world over. The
fingerprints of the medicines were proposed as a visual tool and proof
for many purposes of dealing with medicines particularly traditional.
Before discussing the method of the invention, the existing method of
analytical method is given below.
Existing Analytical Methods of Chemical Standardization:
[0049] Improvement and use of modem analytical methods and instrumentation
have definitely led to excellence in quality control methods of
medicines. Improvement in analysis has led to more precise harvesting of
many herbs as explained above and helped to prepare standardized
extracts.
[0050] Although there are traditional methods of identification of
medicinal plants like organoleptic, microscopic and physical, none of
them gives an authentic identification, as given by a fingerprint of the
plant material, as far as the chemical profile is concerned.
[0051] Hence, it is proposed that the Chromatographic Fingerprint is much
useful for quality control of medicinal plants instead of other
organoleptic and microscopic studies. Since, ultimately it is the
chemical constituents that are largely going to participate in the
therapeutic efficacy of the medicine, along with other properties of the
herbal medicines; the analytical data of the chemical constituents should
be able to provide the authentic efficacy of the medicine. It is like
fingerprint of an individual gives the identity of him.
[0052] Till now Thin Layer Chromatography (TLC), High Performance Thin
Layer Chromatography (HPTLC) and High Pressure (Performance) Liquid
Chromatography are the methods commonly used for the analysis of any
organic or organometallic compounds and finger printing. But, all the
methods have some merits and demerits for an authentic analysis of
medicines. The enclosed Table 12 appearing later part of the description
compare various commonly existing methods of analysis, provide a general
idea of the merits and demerits of them.
[0053] FIG. 4, which is accompanying the specification, shows how the
chromatogram developed from a TLC method is used as a "Chromatographic
fingerprint" on the label of a commercial product. Except the assay of
constituents no more information was given in the finger print.
[0054] After observing the above Table, it is found that the most suitable
technique available for the analysis of a mixture of compounds is
"Chromatography", which gives the profile of the mixture after the
separation and identification with a suitable detector.
[0055] Out of the different types of chromatographic techniques available,
the best suitable is `High pressure liquid chromatography` (HPLC).
Although thin layer chromatography was used till recent times,
advancements brought out in the equipment and separation columns of HPLC
has revolutionized the analytical field of chromatography.
[0056] Most of the pharmaceutical analysis was reported in the form of a
chromatogram with the peaks due to molecules eluted by a mobile phase
mostly reported in the official methods and pharmacopoeias. The
constituents are analyzed after eluting on a HPLC separation column
detected by using any suitable detectors for analysis.
[0057] Usually the chromatographic analysis is done using a reference
standard (internal or external). Without a standard reference material,
the analysis has no meaning because the peak of the chromatogram does not
provide any kind of chemical properties of the compound eluted. Hence,
the confirmation of the qualitative and quantitative properties (spectral
or chemical) of the components are unclear.
[0058] In the qualitative and quantitative analysis of medicines/drugs
(Single or Formulation), the emphasis is given mainly on the spectral and
chemical properties of the components eluted after analyzing the sample.
The analysis is done based on the influence of Electro magnetic radiation
on the analytes (say the UV-Visible radiation) and their response to it.
In the existing method of chromatography, the analytical report i.e., the
chromatogram is not giving any of the chemical properties like polarity
and UV-Visible absorptive properties of the constituents. The
chromatogram is not able to show the presence of the molecules which does
not absorb at that wave length or have a different "Absorbance maxima"
other than the set wavelength (say 225 or 254 nm). If the sample is 100%
pure and if it is a known molecule then the analysis at a fixed
wavelength is acceptable, but it is highly impractical in the case of
medicines where in more than one active molecule are present. Some
examples shown at single wavelength are given in FIGS. 5-12, where in the
chromatograms at various wavelengths are given. None of the single
chromatogram is able to provide complete information about the chemical
properties of the constituents present in the medicine particularly in
traditional medicines where more than one active principle may be
existing. When the chromatograms and the fingerprints are compared, the
utility of the fingerprints can be under stood.
[0059] Hence, any chromatogram presented at a specific wavelength is not
able to provide the complete chemical profile of the ingredients present
in a single medicine and a formulation. So, the chromatogram is partial
in its report, and is not acceptable. Any analytical method, which is not
giving complete information of the analysis, is not scientifically
acceptable.
[0060] In the analysis of herbal medicines, where different types of
molecules are present having different spectral properties (The
absorbance maxima) the chromatogram at a fixed single wavelength will not
be a meaningful analytical report or the chromatogram.
[0061] In the use of herbal medicines, the medicine as a whole is used
with some standard therapeutic conditions prescribed in the ancient
literature and scripts. Hence, the concept of searching for an active
ingredient is said to be incomplete, because it is the total profile that
is responsible for the medicinal property of the medicine. So, any
analytical method, which does not speak about the complete chemical
properties of all of the constituents present in the medicine under
study, will not be useful.
[0062] Also the qualitative and quantitative profile of an herbal medicine
vary due to many ecological factors like time of collection, place of
collection, age of collection and monsoon conditions at the part of
collection and soon.
[0063] It is already mentioned (Frank R Stermirtz et al,) that the synergy
of the other constituents present along with the major constituent is
equally important because the first will not be able to do its function
without the other constituents present in the extract as explained in the
beginning.
B. Prior Art on Therapeutic Standardization:
[0064] I) Traditional Method:
[0065] The great Indian Medical sages have understood and defined the
concept of Indian medicine by clearly defining the properties,
constituents and humors of the living beings. They also understood the
inter and intra relations amongst them. In almost all the traditional
philosophies, the basic concepts include the nature and its role on the
humors of the human beings. It is said that the human body is made of
seven types of constituents (Saptadhatus). The normal disorders
(Tridosha) are of three types. The materialistic properties of any
material in the universe are due to five elements (Pancha bhutas). The
interactions of different permutation and combination of these elements
will influence the health. Hence, the understanding of these properties
will help to understand their physical and chemical properties and so,
there by their therapeutic efficacy. The philosophers in different parts
of world have also developed such concepts suitable for their tradition
and society.
[0066] In ancient times (pre Samhitic and pre Susrutic period in India),
the physicians used Nadisastra (Science of reading pulse) to know the
status of the Tridosha (Vata, Kapha and Pitta) at the time of diagnosis
to know the health status of the patient. The specific type of pulse (not
the heart pulse) is studied to explain the type of disorder pre-dominant
in the patient (History of Medicine in India by Dr Priya Vrat Sharma,
Indian National Science Academy).
[0067] It is used to understand the type of dosha(s) predominant in the
patient at the time of diagnosis and the respective dosha(s) to be
vitiated to cure the disorder. But this art of reading Nadi (Pulse) was
confined to some people of high caliber, personal skill and ability with
lot of discipline. Hence, every traditional practitioner was not able to
practice it.
[0068] To over come this, the art of understanding the physico-chemical
properties of the medicines and the humors of the human being had been
developed and standardized. The inter and intra relations of these
properties with nature which influences health had been studied and
standardized thus the art of pharmacology and pharmaco-therapeutics was
developed by the physicians.
[0069] The therapeutic efficacy of a drug is defined with use of a
substance that is capable of bringing about an (pharmacological) action
in the human body (Kriyagunaval) and due to the collective functioning of
many factors, (samavayikaranam), just as a piece of cloth results because
from its many component threads acting together.
[0070] In the world, there are two main types of living things, the plants
and animals. It is also said that this world is made of five great
elements i.e. Earth, Water, Air, Fire and Space (as said Panchabhutas in
Ayurveda). The basic properties of these materials are of two types,
namely Strong (Powerful) and Mild (Soft). If we accede to this highly
tenable logic, we can say that in this world, all actions are due to
different permutation and combination series of the above properties,
giving a wide range of properties and materials varying in their
intensity.
[0071] In the philosophy of most of the traditional medicine world over,
the co-inherence of the nature of the five constituents is taken into
consideration by which the body is made. They will help in understanding
the disease or disorder of the patient. This coherence is called Purusha
in Ayurveda, Yin and Yang in Chinese medicine. Table 6 appearing later
part of the description gives how the Chinese system has used the above
two factors, how they were classified and defined to standardize the
therapy and diseases.
[0072] Chinese medicine classifies the status of the human body as Yin and
Yang representing sorrow and happiness as mentioned above. These factors
are attributed for various properties of the medicines and living beings.
The maintenance of these factors is done holistically by taking the role
of chemical, physiological and social factors in to consideration. Most
of the time the Chinese medicine has a direct or indirect relation with
various bio energy centers located in the body. The art of acupuncture
uses the same. The other factors that reported in other philosophies have
resemblance with Chinese medicine. After the panchabhautic concept, the
concept of Tridosha (Pitta, Kapha and Vata) plays a major role in the
Indian traditional medicine and the seven constituents (Saptadhatus) by
which the body is made up of Ayurveda believes in the holistic philosophy
of life and emphasis is given for the prevention of diseases rather than
curing of diseases.
[0073] The holistic approach of ayurveda advocates that the soul, mind and
the body are the three integral parts of life and when these are in
dynamic equilibrium and harmony, the state is called good health
(Arogya). When they are in inequilibrium and disharmony, the state is
called disease. (Vaishamya).
[0074] According to Ayurveda, Tridosha maintains the physiological
features of various systems in dynamic equilibrium status. In other
words, harmony of tridoshas bestows good health, disharmony results to
disease. Hence, most of the time the tridoshas are dealt with, in curing
any disease. The selection of drug is made for the disease that should be
dealt with.
[0075] A disease is defined as "Any thing that brings a sadness and grief
to this person (Purusha) is a disease. They are of four types 1.The
accidental (agantavaha) 2.The body born (Sarirah) 3.The Mind born
(Manasah) and 4. The natural (Swabhavikah). It is for this reason, most
of the traditional concepts deal with both psychosomatic factors to cure
the disease along with a disciplined and standardized method of life.
[0076] The diseases were classified into three classes generally. 1. The
curable (Sadhya) 2. The Mitigateable or manageable (Yapya) and 3. The
incurable (Asadhya). As said above, it is mostly considered as those
bodily diseases having their source arise by the incompatibilities of the
thridoshas viz., Vata, Kapha and Pitta and blood individually or in
combination with one another. But, the diseases that arise not due to the
above reason like psychological are dealt in a different way. That is why
any traditional concept is used to take all the psychosomatic factors in
to consideration to deal with a disease. The individual properties of the
doshas are explained as given below.
[0077] Broadly it is outlined that the Vata or vayu dosha deals with
endocrinological, neuromuscular and nervous activities all those that
cause the major or the gross dynamics of the life, the foods that cause
gas formation can be classified in this category. Pitta dosha refers to
digestion and chemical functions or rasa kriya in general and Kapha dosha
includes factors providing form, stability, and cohesion and lubrication
factors. As the first dosha, `Vata` is considered to influence the other
two it is considered as the key factor for any disease. An elaborate
description of these humors is given in elsewhere in the body of the
text.
[0078] The decrease of vata leads to general dullness in activity. Hence,
the drugs, which decrease this dullness, will be of Vata Hara. The
decrease of digestive capacity is called as pitta dosha. A medicine,
which increase the digestive capacity or activate bile mechanism, will be
of Pitta Hara in nature. The decrease of liquidity or mucous will lead to
roughness, an internal burning, an emptiness in stomach, a looseness in
the joints, thirst, weakness and a continues insomnia. These are the
basic symptoms of kapha disorder. Any medicine that vitiates this
disorder will be of Kapha Hara in nature.
[0079] A detailed description of all the factors is given for various
philosophies in order to under stand more generally about different
traditional medicines world over. Table No 1 and Table No 2 (which are
appearing in the later part of the description) gives an elaborate
description of the Indian Ayurvedic philosophy and various components in
it.
[0080] Hence, to understand the therapeutic efficacy of a medicine or
food, one needs to understand their physical and chemical properties. In
the ancient times people use to understand these properties using the
organoleptic methods like the taste, the smell and the color of the
materials. The basic properties classified were 1. Taste (Rasa), 2.
Quality (Guna) 3. Potency (Virya) 4. Post assimilative status and effect
of the constituents (Vipaka) and 5. Special action (prabhava, geometrical
and optical isomer molecules)
[0081] It is these three factors namely, the Doshas (Disorders), the
Dhatus (constituents) and the Malas (excreta) that are mainly to be dealt
for curing a disease or a disorder. If the above-mentioned properties of
the medicines tally with the dosha, it will be vitiated or neutralized,
thus the disease is cured.
[0082] The classification and differentiation of drugs according to
Ayurvedic pharmacodynamic and genetic principles vary from one situation
to another according to doshic predominance of the patient. In other
words there is a relation between the dravya gunas (medicinal properties)
and doshas (disorders). Addition or deletion of one or more drugs may be
necessitated to treat an identical disease with the patients with
different individual doshas or combination of doshas. Hence, Ayurvedic
pharmacotherapy is more individualistic according to dosha predominance
of the patient and not generalized as in the case of modern medical
pharmacotherapy. Identification of properties (Rasa, Guna, Veerya, Vipaka
and Prabhava) compatible to doshas is unique and more reliable in
Ayurvedic pharmacotherapy.
[0083] ii) Modern Method of Therapeutic Standardization:
[0084] The existing pharmacotherapy has not taken the above mentioned
concepts into consideration. Phytochemists are interested only in
isolation, purification and structural elucidation of the active
principles isolated from the plants and they passed on them to
pharmacologists to study their biological activity. The pharmacologists
in turn screen the molecule(s) for pharmacological activity, establish
its mechanism(s) of action and substantially rate its efficacy in
comparison with the existing standard drugs used in modern medicine.
[0085] This concept is in no way going to help the traditional medical
practitioners since the isolation of the active principle(s) drastically
change the holistic character of the medicines and their therapeutic
efficacy.
[0086] Instead of assaying the solvent extraction fractions, active
principles etc., obtained from the individual plants, the analysis of
total extract from a medicine using a solvent compatible to the human
cells and cell membranes of the body will be of much use to evaluate the
pharmacological activity of such medicines.
[0087] In the modern clinical trials conducted for the therapeutic
standardization, they are done in three phases (four in the case of
international utility), involving large number of people. The information
regarding a new medicine to be submitted to Drug Controller generally
consists of: [0088] 1. Chemical structure [0089] 2. Pharmacological
class [0090] 3. Formulation details [0091] 4. Data on animals including
data on toxicity studies [0092] 5. Data on clinical pharmacology
including pharmacokinetics (Behavior of the drug in the human body)
[0093] 6. Pharmacodynamics (Actions of the drug inside the body) [0094]
7. Special studies and status of the drug in the rest of the world.
[0095] 8. Data on Bio-Equivalence studies
[0096] The Phase one study is mainly concerned with assessing the drug's
safety to know how the medicine is absorbed, metabolized in the human
body and excreted, also it envisages to estimate the side effects and the
dosage.
[0097] The phase two studies are dedicated to test the efficacy in a
randomized way. One group of patients will be given the actual medicine
and the second with placebo.
[0098] In the phase three study, a large scale testing will be taken up to
study the effectiveness, benefits and the range of possible adverse
reactions of the drug. After successful completion of this step, the
industry will go for marketing the drug.
[0099] In late phase III and IV studies, pharmaceutical companies will
have several objectives. Studies will help to know the efficacy of the
new drug compared to an existing drug. The long-term effectiveness and
impact on a patient's quality of life due to the new drug will be known.
The cost effectiveness of the drug therapy relative to other traditional
and new therapies will be known.
[0100] But all the above studies are costly and time consuming. They will
not be taking into account of the role of the ecological factors, the
genetical discipline (as practiced in the Indian family and marriage
relations), the psychological, the social and other variable parameters
of the patient in to consideration. This will make the effectiveness of
the drug limited to a particular group or genetic type of people.
C. Prior Art of Barcoding and Enterprise Resource Planning (ERP) Customer
Relationship Management Applications:
[0101] The modern method of making any commercial goods proprietary is
Bar-coding. For all commercial transactions, the barcode is widely used
in many ways. To make the medicines identified as proprietary goods, a
novel method of bar coding is proposed in this invention.
[0102] It is reported (Peernet bar-code store (Java Active X servlet
e-business)) that 1800 character and 2700 digits (Even 9,99,999 numbers)
can be fed to a commercially available bar coding software to generate a
barcode of any item. When a digital value and/or numerical number is
given to the bar-coding software it generates a specific barcode pattern
by the logic specified in the software proprietary for a user.
[0103] The barcode thus generated will present and display the attached
"display window" file information having all details of the
product/label, when a barcode readable vending machine sees (through
electronic eye or sensor) the barcode on the product. The barcode can be
read from any ERP and CRM applications world wide through network.
Presently the catalogue numbers are being used for bar coding the
medicines and related products which does not specifically contain any
chemical property of the product as proposed in the method.
Objectives of the Present Invention
[0104] The main objective of the invention is to propose a novel method of
chromatographic finger printing, chemical and therapeutic standardization
and bar coding of organic and organo-metallic molecules from a plant,
animal or a naturally available or man made materials used as medicines.
[0105] Another objective of the present invention is to provide a novel
chromatographic finger printing of herbal medicines and formulations
which obviates the drawbacks detailed above.
[0106] Another objective of the present invention is to provide a complete
chemical analysis of the constituents present in the medicine under study
and their conjugative properties indicating the therapeutic efficacy as
per the traditional concepts of the medicine using new software
developed.
[0107] Still another objective of the present invention is to provide a
novel method for chromatographic fingerprinting of herbal medicines
useful for the quick identification of the actual profile of the
compounds present in the medicine under use along with their therapeutic
efficacy of the constituents.
[0108] In yet another objective of the present method is to provide a
novel chromatographic finger printing of herbal medicines and
formulations using the contour and 3-D chromatograms of the herbal
medicines and formulations.
[0109] In yet another objective of the present invention is to provide a
novel method for chromatographic finger printing of herbal medicines
useful to check the adulteration of the compounds present in the medicine
under use.
[0110] Yet another objective of the present investigation is to prepare a
standard analytical parameters like extraction with same solvent ethyl
alcohol, same run time 0-60 min, same mobile phase acetonitrile along
with phosphate buffer having a pH in the range of 5.5-7.5, and a same
UV-Visible Range of 200-800 nm.
[0111] Yet another objective of the present invention is, to categorize
and quantify the constituents of a medicine based on polarity and
conjugation from 3-D and contour chromatograms and assess the therapeutic
efficacy of the medicine on which humors it is going to act (vitiate).
[0112] Yet, another objective of the present invention is to provide a
barcode for the selected peak of a molecule given in the image.
[0113] Yet another objective of the present invention is to prepare a
database of barcodes for the fingerprints developed useful for all types
of database applications.
[0114] Yet another objective of the present investigation is to generate
display windows for all the samples of the fingerprints having the
details of the samples like 3-D and Contour fingerprints, the barcode,
details of the origin (Industry or Country), manufacturing date, date of
expiry, reported dosha, individual constituents used, their assay, batch
number, lot number, M.R.P (maximum retail price) etc.
[0115] Yet, another objective of the present invention is to attach the
display windows with the respective barcodes, facilitating to deal with
display windows in all applications whenever they are used as a source of
data and information.
[0116] Yet another objective of the present invention is, to prepare a
database of display windows thus generated and attached to the respective
barcodes, to use in the Enterprise Resource Planning (ERP) and Customer
Relationship Management (CRM) applications for all commercial networking
transactions of the medicines and samples.
[0117] Yet another objective of the present investigation is to prepare a
database of barcode and display windows and any information, specially
required for the regulatory authorities to control the movement of the
medicines in and out of the country.
[0118] Yet, another objective of the present invention the UV-Visible
spectra of the compounds will provide the conjugative properties of the
molecules and the concentration of the individual concentrations of the
molecules along with the polarity of the molecules.
[0119] Yet another objective of the present invention the use of finger
print of contour and 3-D chromatograms will be the basis for the
identification of chemical constituents to limit the scope of the
invention.
[0120] Yet another objective of the present invention is to develop a
method of fingerprinting for the adulterated food and drug samples,
substituted and contradictual food and drug samples and commercial
samples of food and drug samples and to identify the pure and
adulterated.
[0121] Yet, another objective of the present invention is to develop a
method of fingerprinting for the organic and organo-metallic constituents
in any type samples to identify the chemical constituents present in it
for various purposes of quality control and process standardization.
[0122] Yet another objective of the present invention is to develop a
method of fingerprinting for the Allopathic, Ayurvedic, Homoeo, Siddha,
Unani, Chinese, Tibetan and Kampo (Japanese) medicine samples for the
quality control and chemical and therapeutic standardization
[0123] Yet, another objective of the present invention is to develop a
method of fingerprinting for the study of variation of chemical
constituents in naturally occurring or synthetically prepared samples and
to identify and standardize the chemical constituents in them.
[0124] Yet another objective of the present invention is to develop a
method of fingerprinting for the study of variation of chemical
constituents in naturally occurring or synthetically prepared samples and
to identify and standardize the variation in chemical constituents in
them due to Geological, Ecological, Genotypic and Phenotypic variation
factors.
[0125] Yet, another objective of the present invention is to develop a
method of fingerprinting for the study of chemical constituents in herbal
products of single and formulated medicine samples and to identify the
chemical constituents in them for chemical and therapeutic
standardization.
[0126] Yet, another objective of the present invention is to develop a
method of fingerprinting for the study of variation of chemical
constituents in biological samples and to identify and standardize the
chemical constituents in them.
[0127] Yet, another objective of the present invention is to prepare a
large database, which will give many generalizations of the therapeutic
efficacy of a particular group of plants, classified as a group for a
particular disease or therapeutic classification.
[0128] Yet another objective of the present invention is to provide a
method which enables to understand and standardize the Physico-Chemical
properties of the medicines like color used in traditional method of
therapeutic standardization using conjugative and polarity properties of
the individual constituents and the whole medicine.
[0129] Yet another objective of the present invention is to provide a
method which enables to understand and standardize the Physico-Chemical
properties of the medicines like Taste (Rasa) namely Sour, Salty,
Pungent, Bitter, and Astringent (Amla, Lavana, Katu, Tikta, and Kashaya
as said in Ayurveda respectively) used in traditional method of
therapeutic standardization using conjugative and polarity properties of
the individual constituents and the whole medicine.
[0130] Yet, another objective of the present invention is to provide a
method, which enables to understand and standardize the Physico-Chemical
properties of the medicines like Quality, Potency, Metabolite after
assimilation or such modifications and Specific properties like Chirality
of the molecules (Guna, Veerya Vipaka, and Prabhava respectively as said
in Ayurveda)
[0131] Yet another objective of the present invention is to provide a
method which enables to understand and standardize the Physico-Chemical
properties of the medicines like Heavy, Light, Cold, Hot, Soft Lubricated
Supple, Dry, Slow, Sharp (Guru, Laghu, Sheeta, Ushna, Snigdha, Manda,
Teekshna respectively as said in Ayurveda) used in traditional method of
therapeutic standardization using conjugative and polarity properties of
the individual constituents and the whole medicine.
SUMMARY OF THE INVENTION
[0132] This invention relates to a method for detection and identification
of principles from extracts of plants or animal, natural or synthetic
sources, using chromatographic finger printing techniques, said method
comprising the steps of: [0133] i.) extracting the organic or
organo-metallic molecules using a suitable solvent; [0134] ii.)
subjecting the extract obtained in step (i) to the separation analysis,
using High Pressure Liquid Chromatography techniques; [0135] iii.)
generating contour and 3D chromatograms of the ingredients eluted based
on the pH and polarity; [0136] iv.) converting the 3-D and contour
chromatogram obtained into a colored image, analyzing the colored image
for its individual colors using the co-ordinates denoting all its
3-dimensional properties of the said image by using an in-built software;
[0137] v.) denoting the concentrations of the various constituents
eluted with time; [0138] vi.) generating a chromatogram based on color
analyzed, having peaks at various retention times along with conjugative
properties of the molecules; [0139] vii.) identifying the compounds in
the said ingredients by the UV-Vis absorptive properties of the various
constituents in the image; [0140] viii.) identifying, determining and
classifying the compounds eluted as polar, medium polar and less or
non-polar based on the polarity and conjugative properties; [0141] ix.)
generating a barcode for a selected peak using the X axis as Retention
Time, Y axis as Wavelength, R as number of Red Pixels, G as number of
Green Pixels and B as number of Blue Pixels; and [0142] x.) generating a
database of fingerprints and barcodes and identifying the respective
compounds in the samples.
DETAILED DESCRIPTION OF THE PRESENT INVENTION
[0143] Accordingly, the novel basis of the present method is, presenting
the spectral properties of the chemical constituents displayed in 3-D and
contour chromatograms as a novel method of fingerprinting. The
chromatogram generated by this method provides the conjugative and
polarity properties of the individual molecules present in the medicines
giving the therapeutic efficacy of the medicine.
[0144] In a molecule the UV-Visible absorbance capacity of the molecules
depends on the structure of the molecules. When the double bonds or
triple bonds are present in the molecules alternatively in the structure,
it is called as conjugated. The more the molecule is conjugated the more
it will be chemically and biologically active. Hence the more the
molecule is conjugated the more it will be therapeutically active. Thus,
the measurement of conjugative properties will give the therapeutic
efficacy of a medicine. Hence, the use of conjugate property for the
therapeutic standardization is the novelty of the present invention.
[0145] A novel method is proposed for the quality control of herbal
medicines and formulations mostly useful for the fingerprinting and
standardization (chemical and therapeutic) of Traditional Medicines
unlike a method being used for analyzing only active ingredient (which is
not known in many herbal medicines) for the analysis of medicines at a
single wavelength. It gives the total profile of the chemical
constituents present in the traditional medicines along with physical and
chemical properties of the compounds (Say UV-Visible absorptive property
and polarity property). In the first part of the method, an image of the
fingerprint of the medicine will be generated. But as image cannot
becomes analytical data, a computer-based method is developed to give the
qualitative and quantitative data of the ingredients in the form of an
analytical chromatographic report. The same is proposed as a novelty of
the method of the invention.
[0146] The reactivity of any molecule will depend upon the number of
double and triple bonds existing in the molecules along with the
electrophilic and nucleophilic sites on the molecule. The moieties
donating electron and accepting electron will create difference in the
total electrical charge of the molecule. This makes the molecule polar.
Hence polarity of the molecules will provide information about the
capability of a molecule to donate or accept the electron with another
molecule. This will control the activity of a molecule. Thus, the
information of the polarity of a molecule will speak about the reactivity
of the molecule. In the present method, the chromatogram provided by the
method will give the conjugative and polarity properties of the
constituents present in a medicine in the finger print. Thus, this method
is used for the standardization of the medicines to know the therapeutic
efficacy of a medicine using their conjugative and polarity properties of
the medicines. This is the novelty of the proposed method.
[0147] As said above the UV-Visible spectra and polarity of the compounds
will indicate the conjugative and polarity properties of the compounds
and thus indicating the chemical/medicinal property of the medicines.
This profile of spectra of all the constituents in a single picture, "the
finger print" as proposed now will become the blue print of the
constituents present in herbal medicines and formulations. This becomes a
superior method of identification and standardization of herbal medicines
than the existing, as the peaks will express the UV-VIS. Properties or
conjugative and polarity properties of the constituents, unlike in a
conventional chromatogram taken at a single wavelength along with the
quantification of the constituents.
[0148] As described in the traditional standardization methods the colors
of the medicines were used to know and standardize their therapeutic
efficacy. The colors of the molecules are understood by their absorptive
properties of the radiation of the UV-Visible range of radiation. Based
on the structure, functional groups, conjugation, and the extent of
unsaturation the absorbance of a particular wavelength depends. The more
the molecule is conjugated the longer the wavelength of absorption will
be. Hence, the UV-Visible absorbance of any molecule is widely used in
the qualitative and quantitative properties of the constituents. The
colors and the therapeutic efficacy of various medicines were given in
the ancient literature.
[0149] Ultimately the colors of the molecules are due to a specific
chemical nature of the molecule. When the same is studied, the chemical
property can also be understood. In ancient times the colors of the
flames were used for the quality control of metals and related products
this, involves the basic spectrophotometric principles. Thus, study and
understanding of the interaction of the electromagnetic radiation will be
useful to study the chemical nature and thus the therapeutic efficacy of
the medicines. The same principle has been used in the present
spectrop
hotometric method of fingerprinting and standardization. The main
novelty of the present method involves in the "division of the
fingerprint into different therapeutic zones based on the scales of
wavelength (Conjugation) and retention time (Polarity) to understand the
therapeutic efficacy (in traditional terms) of a single or a formulated
medicine" using an instrumental and software based program.
[0150] Using the computer-based software developed, a barcode is generated
for a selected peak of a molecule given in the image. Where, X is the
Retention Time, Y is the Wave length in contour chromatograms and
absorbance in 3-D chromatograms, R the red color indicating the highest
concentration of the constituent, G the green color indicating the lesser
concentration of the constituent and B Blue color indicating still lesser
concentration of the constituent are the coordinates provided by the
present software, is feed in any commercially available re-salable bar
coding software, added in the present software generates a barcode for a
single constituent, or for many constituents. The Image of the
fingerprint is viewed on a display window attached to it. This will be
displayed whenever the electronic eye of the vending machine reads the
barcode. This makes the image (Finger print) and barcode proprietary for
a product of an industry or a country. This is claimed as another novelty
of the method of the invention.
[0151] When the polarity of the column is fixed and the polarity of mobile
phase is varied constantly in an increased or decreased order, on a
reverse phase column, the constituents present in the sample will elute
in the order of high polar constituents eluting first the medium polar
constituents next followed by non-polar constituents. Care is taken in
eluting the constituents in the order of increased or decreased order of
polarity such that no constituent of any polarity will be left un-eluted
from the column achieving total elution. The order and properties of
polarity and elution in the case of normal phase columns are applicable
same as in the case of reverse phase column but in reverse. In a normal
phase column the non-polar constituents will elute first and followed by
polar constituents, based on order of polarity of the mobile phase used
for elution.
[0152] Thus, a fingerprint developed having the chemical constituents
arranged in the increased or decreased order of polarity will help to
bring therapeutic generalizations about the medicines. This is another
novelty of the proposed method.
[0153] The image of contour chromatogram developed after the analysis is
divided in to three zones on X and Y-axis. The conjugative property
(Absorption of a particular wavelength of radiation) is taken on Y-axis
and polarity is taken on the X-axis, as the elution of the constituents
is controlled using the polarity of the mobile phase composition. Now as
reported in literature the Y axis is scaled as per, the therapeutic
efficacy based on wavelength (color). The entire image is divided in to
six chambers wherein the chemical constituents have specific conjugative
and polarity properties. This in turn is proportional to the therapeutic
efficacy of the constituents in the chamber. Thus when a medicine is
fingerprinted, based on the color represented for the absorption of a
specific wavelength and having a specific polarity, the total colors in
that zone is calculated and interpreted for the therapeutic efficacy of
the constituents present in it. Thus, the holistic therapeutic
standardization and chemical standardization is achieved using this
method.
[0154] Mostly the elution of the samples were done from high polarity
mobile phase to low polarity mobile phase. Thus in the finger prints the
constituents present in the first zone (Zone-1) will be of high polar in
nature. The same pattern applies to the other zones, the medium polar
constituents eluted in the medium polar zone (Zone-2) and the low or
non-polar constituents eluted in the non-polar zone (Zone-3). This
pattern reverse when a normal phase column is used due to its elution
property as described above.
[0155] Most of the high polar molecules are highly reactive chemically,
thus biologically. When they enter the first part of the digestive system
mouth, they will immediately start acting on the biological system and
the enzymes present there. Then the constituents will enter the stomach
and intestine where they will under go different changes (Post
assimilation effects, Vipaka in Ayurveda) due to the digestive juices and
their enzymes present in the part. In the process of absorption, the
moment the molecules of high activity (high polar) immediately start
interacting with the biological system and show their therapeutic
properties. This is compared that in Ayurveda, the intestinal part of the
human body is classified as Pitta zone, where the high polar molecules
are playing a major role. The heat causing mechanism will play an
important role in the diseases and biological mechanisms related to. It
indirectly indicates the molecules of high reactive, the high polar
molecules. After the absorption, the blood with all the absorbed
constituents will carry them to heart and the parts related to it. Then
the blood will be sent to different parts of the body. In Ayurveda, the
upper portion of the human body is defined as the Kapha zone, where the
cold mechanism will be playing an important role. Thus, the molecules of
medium polar molecules will play an important role in the mechanisms
related to this zone.
[0156] The low polar and non-polar constituents will be able to enter to
the human body only through blood transfer, Thus the body organs where
the mechanism of availability of the chemical constituents is only by
blood, will be coming in the last category of the polarity. The non-polar
oils, fats and other such molecules and mechanisms in the human body are
classified as Vata disorders and all such disorders are cure using the
same type of materials.
[0157] The low and non-polar constituents will be eluting in the last zone
of the fingerprint. Thus, this zone (zone-3) is considered as Vata zone.
Thus, the basic humors of the molecules can be identified based on their
polarity, which facilitates to know on what disorder (dosha) it is going
to act upon. Thus, the present method is useful for the therapeutic
standardization of the medicines.
[0158] Thus the total constituents present in the Zone-1 Pitta zone,
Zone-2 Kapha zone, Zone-3 Vata zone are present in the form of a pie
diagram which represents the ratio of the efficacy of the medicine on
each of the disorder. Thus, medicines having constituents in the order of
50:20:30 will be medicines of tridoshahara of the order of 50%: 20%: 30%.
Thus, the therapeutic efficacy is standardized quantitatively. The
increase or decrease of any one or two of the other doshas is done by
formulating medicine by adding other medicines and prepare a suitable
formulation needed to cure a specific individual.
[0159] Thus, a fingerprint having the scales of conjugation, absorbance
and polarity the 3-D chromatogram will give information about the
therapeutic efficacy of the medicine. Analyzing it using all its three
dimensional properties of the said image will do quantification of 3-D
chromatograms of the medicine. For example if the 3-D chromatogram is
considered as a `cap with a hood` the matching of the entire cap 3
dimensionally, with another sample of different qualitative and
quantitative properties, the extent it matched will be presented as an
analytical report qualitatively and quantitatively. Here the hood of the
Cap is compared to the peak of the molecule at a particular wavelength. A
sample with more number will like a cap with many hoods. Thus the
matching of the three dimensional coordinates will provide a foolproof
method of comparison and analysis. The coordinate it matched will give
qualitative and the extent it matched will give the quantitative data of
the sample understudy. This is made possible by special software prepared
for this purpose. This becomes an ultimate method of quality control.
This is another novelty of the method of the invention.
[0160] The invention also relates to a software based data processor of 3
D chromatograms and color contour image of an ingredient, said processor
comprising computing means and capable of:
[0161] a. an analyzer (extracting colors) for analyzing the colored
contour image based on the selection of various colors (with standards
mentioned in release notes, life cycle, processing) denoting the
concentrations of the various constituents eluted with time, and polarity
based on retention time;
[0162] b. an analyzer for analyzing the 3-D chromatograms of the medicine
using all its 3 dimensional properties of the image;
[0163] c. a means for generating a chromatogram having peaks at various
retention times along with conjugative properties of the molecules eluted
with time in a specified order of polarity;
[0164] d. an identifier for identifying the compounds in the said
molecules by the UV-Vis absorptive properties of the various constituents
in the image;
[0165] e. a means for correlating the reported biological, therapeutic
activity of the of various constituents present in the medicines
understudy based on the polarity and the conjugative properties of the
molecules by dividing the fingerprint into therapeutic zones on X and Y
axis;
[0166] f. a means for generating a barcode for a selected peak(s) using
the image coordinates viz., X for retention time, Y for wavelength, R for
number of red pixels, G for number of green pixels and B for number of
blue pixels, provided by the proposed software;
[0167] g. a means for generating a database of fingerprints and barcodes
for the samples, facilitating all kinds of database utilities like
Enterprise Resource Planning (ERP) and Customer Resource Management (CRM)
applications; and
[0168] h. a means for generating a database of the `display widows` for
all the samples to be used by the ENTERPRISE RESOURCE PLANNING (ERP) and
CUSTOMER RELATIONSHIP MANAGEMENT (CRM) type of business applications.
Abbreviations Used in the Patent Document
[0169] 1. ERP: Enterprise Resource Planning [0170] 2. CRM: Customer
Relationship Management [0171] 3. UV-Visible: Electromagnetic radiation
in the range of 200 nm to 800 nm [0172] 4. Organic molecule: A molecule
having basic elements of C, H, N, O, S in its structure. [0173] 5.
Organo-Metallic molecule: A molecule having a metal along with basic
elements of C, H, N, O, S in its structure [0174] 6. Contour
Chromatogram: A type of chromatogram displayed in the data generated from
a Photo Diode Array detector, which scans the sample with electromagnetic
radiation in the range of 200 nm to 800 nm. The chromatogram thus
generated will provide Retention time on X-axis, range of absorbance (nm)
on Y-axis. Different colors will be used to represent different
concentrations of the individual constituents. [0175] 7. 3-D
chromatogram: This is also generated using the same set of equipment as
given above. It will be more informative providing the UV-Vis spectra of
each of the in-gradients after separation from a mixture. It helps to
identify the constituents using the spectrum. [0176] 8. Ayurveda: An
Indian philosophy written by Indian sages explaining organized science of
medicine and health discipline. [0177] 9. Oshadisukta: a chapter in
Rigveda giving the details of the properties of the medicines used as
medicines. [0178] 10. Rasa, Guna, Veerya, Vipaka, and Prabhava:
Different Physico-Chemical properties of the medicines and materials used
to understand the efficacy of the medicines used in Indian system of
medicine. [0179] 11. Lokapurusha Samanya: Law of Uniformity of Nature
[0180] 12. Tri doshas: three humors using which the human body is studied
viz., Pitta, Kapha and Vata used in Indian system of medicine. [0181]
13. Prakriti-Purusha: The first one is compared to Mother Nature (woman)
and the second to person (man) used in Indian system of medicine [0182]
14. Pitta: A term used in Indian system of medicine for one of the humors
in the bddy in Indian system of medicine to denote the personality or a
disease which denotes the digestion and chemical functions or rasa kriya
in general in the human body. [0183] 15. Kapha: A term used in Indian
system of medicine for one of the humors in the body in Indian system of
medicine to denote the personality or a disease which denotes the factors
providing form, stability, and cohesion and lubrication factors in the
human body. [0184] 16. Vata: A term used in Indian system of medicine
for one of the humors in the body in Indian system of medicine to denote
the personality or a disease which denotes the neurological and
endocrinological, and nervous activities in the human body. [0185] 17.
Geological factors: Global variation in soil nature and ground water
constitution etc related to earthly components. [0186] 18. Ecological
Factors: Global variation in tropical regions, monsoon conditions and
temperatures. [0187] 19. Organoleptic methods: Methods of identification
of the properties of medicines like 1. Taste (like Sour (Amla), Salty
(Lavana), Pungent (Katu), Bitter (Tikta), Astringent (Kashaya)) 2. Color,
3. Odor and 4. Texture etc., using human sensory organs. [0188] 20.
Tastes (Rasa Physico-Chemical properties) Properties visibly seen (Color,
Size) and felt (Texture) and all physical properties and properties like
taste and medicinal related to the chemistry of the individual
constituents present in the medicines. [0189] 21. The medicines were
standardized using their properties like Taste (Rasa), Quality (Guna)
Potency (Virya), Post assimilative status and effect of the constituents
(Vipaka) and Special action (Prabhava,) [0190] 22. Saptadhatus: The 7
elements like Rasa (Body fluids), Rakta (Blood), Mamsa (Muscle), Majja
(Bone marrow), Asthi (Skeleton System), Medas (Fat) and Shukra
(Reproductive) constituents present in the human body used in Indian
system of medicine. [0191] 23. Panchbhutas: The 5 natural elements like
Prithivi (Earth), Ap (Water), Teja (Fire), Vayu (Air) and Akasha (Space)
present in the world used in Indian system of Medicine [0192] 24.
Nadisastra: A science, which explains the health status in the human
body, used in Indian system of medicine by studying the pulse of the
person. [0193] 25. In Indian System of Medicine, Factors causing disease
are explained as Agantavaha (accidental), Sarirah (body born), Manasah
(Mind born) and Swabhavikah (natural) [0194] 26. The diseases were
classified into three classes as per Indian System of Medicine They are
Curable (Sadhya), Mitigateable or manageable (Yapya), The incurable
(Asadhya) [0195] 27. Conjugative property: If a molecule has alternative
single and double bond and electron donating and accepting property it is
called conjugative. This is seen in the UV-Visible spectrum of a
molecule. Based on the energy absorbed for the excitation of Sigma and Pi
electrons in a molecule from the electromagnetic radiation, the molecule
will absorb a specific wavelength of radiation. The absorbance maxima of
a molecule will thus indicate the conjugative property of the molecule
under study. [0196] 28. Polarity property: If a molecule has difference
in its electrochemical property, it is called polar. This depends on the
atoms attached to the molecule with electron donating (nucleophilic) or
electron accepting (electrophilic) moieties or functional groups the
molecule will have a difference in its electrical charge on its molecular
orbital. This makes the molecule to have a positive end and negative
ends. This type of molecules is called polar molecules. The extent and
type of electrical charge will make the molecule polar, medium polar and
non-polar in nature. [0197] 29. Gradient or ternary system of HPLC: A
HPLC instrument having two or three liquid pumps to vary the ratio of the
aqueous or non-aqueous solvents. This will help to control the total
polarity of the mobile phase as per the requirement. Some abbreviations
used in software: [0198] 1. JDK: Java Development Kit [0199] 2. Con:
Contour Chromatogram [0200] 3. 3-D: 3-Dimensional Chromatogram [0201]
4. WOS: Without Scale [0202] 5. X: Represents the Retention Time of the
chromatogram [0203] 6. Y: Represents the absorbance in the 3-D
chromatogram and wave length range in contour chromatogram [0204] 7. R:
Intensity of red color at a particular pixel position [0205] 8. G:
Intensity of green color at a particular pixel position [0206] 9. B:
Intensity of blue color at a particular pixel position
EMBODIMENTS
[0207] One of the present embodiments of the present invention relates to
a method for chromatographic finger printing, chemical and therapeutic
standardization and bar coding of organic and organo-metallic molecules
from a plant, animal or a naturally available or man made materials.
[0208] Another embodiment of the present invention relates to a novel
method for chromatographic finger printing of herbal medicines and
formulations, which obviates the drawbacks detailed above.
[0209] Still another embodiment of the present invention relates to a
method for a complete chemical analysis of the constituents present in
the medicine under study and their conjugative properties indicating the
therapeutic efficacy as per the traditional concepts of the medicine
using new software developed.
[0210] Still another embodiment of the present invention, relates to a
method of novel chromatographic finger printing of medicines that is
useful for the quick identification of the actual profile of the
compounds present in the medicine under use along with their therapeutic
efficacy of the constituents.
[0211] In yet another embodiment of the invention, an embodiment of a
novel concept of chromatographic finger printing of herbal medicines and
formulations using the contour and 3-D chromatograms of the herbal
medicines and formulations is proposed. They were developed on a Photo
Diode Array detector (PDA) of a High Pressure Liquid Chromatograph. This
delineates the data of the spectral properties of the constituents
present in the herbal medicines eluted under experimental analytical
conditions.
[0212] In yet another embodiment of the present invention relates to a
method for the chromatographic finger printing of extract from a medicine
of any nature containing molecules that absorb Ultraviolet and Visible
range of radiation (200-800) or of any range of electromagnetic
radiation.
[0213] In another embodiment of the present invention, the UV-Visible
spectra of the compounds provide the conjugative properties of the
molecules and the concentration of the individual concentrations of the
molecules.
[0214] In another embodiment of the present invention the fingerprints
developed for a same medicine extracted under different pH values are
helpful to understand the drug release in the intestine system at
different pH values of an individual.
[0215] In yet another embodiment of the present invention, the UV_VIS
spectra of all the constituents are shown in a single image "The
Chromatographic Fingerprint"
[0216] In yet another embodiment of the present invention the finger print
becomes the blue print of the constituents present in a herbal medicine
or formulation for an assay and quick identification of the medicine
understudy.
[0217] In yet another embodiment of the present invention, the fingerprint
using the contour and 3-D chromatogram is the basis for the
identification of chemical constituents existing and/or formed new.
[0218] In yet another embodiment the UV-Vis spectra and polarity of the
compounds indicates the conjugative and polarity properties of the
compounds and thus indicating the chemical/medicinal property of the
medicines. This profile of spectra of all the constituents in a single
picture, "The Finger Print" as proposed now becomes the blue print of the
constituents present in herbal medicines and formulations. This becomes a
superior method of identification and standardization of herbal medicines
than the existing, as the peaks express the UV-VIS. Properties or
conjugative and polarity properties of the constituents, unlike in a
conventional chromatogram taken at a single wavelength along with the
quantification of the constituents.
[0219] In yet another embodiment of the present method the "division of
the fingerprint into different therapeutic zones based on the scales of
wavelength (Conjugation) and retention time (Polarity) to understand the
therapeutic efficacy (in traditional terms) of a single or a formulated
medicine" is done by using an instrumental and software based program.
[0220] In yet another embodiment of the present invention, from a large
database prepared using this method, it gives many generalizations of the
therapeutic efficacy of a particular group of plants, therapeutically
classified as a group for a particular disease.
[0221] In yet another embodiment of the present invention using the X, Y,
R, G, B as coordinates of a selected peak in the fingerprint, a barcode
is generated using a bar coding software, which makes the medicine
proprietary for an industry.
[0222] In yet another embodiment of the present invention, 3-D
chromatogram of the medicine is analyzed using all its 3 dimensional
properties of the said image. If the 3-D chromatogram is considered as a
cap with a hood, the matching of the entire cap 3 dimensionally, with
another sample of different qualitative and quantitative properties, the
extent it matched is presented as an analytical report qualitatively and
quantitatively. Here the hood of the Cap is compared to the peak of the
molecule at a particular wavelength. A sample with more number will like
a cap with many hoods. Thus the matching of the three dimensional
coordinates will provide a foolproof method of comparison and analysis.
The coordinate it matched will give qualitative and the extent it matched
will give the quantitative data of the sample understudy. This is made
possible by special software prepared for this purpose. This becomes an
ultimate method of quality control.
[0223] In yet another embodiment of the present invention relates to a
method to provide a novel chromatographic finger printing of herbal
medicines and formulations using the contour and 3-D chromatograms of the
herbal medicines and formulations is proposed. They are developed on a
P
hoto Diode Array detector (PDA) of a High Pressure Liquid Chromatograph.
This delineates the data of the spectral properties of the constituents
present in the herbal medicines presented in a specific order of polarity
under experimental analytical conditions.
[0224] In yet another embodiment of the present invention relates to a to
use UV-Visible spectra of the compounds which provides the conjugative
properties of the molecules and the concentration of the individual
concentrations of the molecules along with the polarity of the molecules.
[0225] In yet another embodiment of the present invention relates to a
method to provide the UV_VIS spectra of all the constituents shown in a
single image "The Chromatographic Fingerprint". The fingerprint thus
becomes the blue print of the constituents present in a single medicine
or formulation for an assay and quick identification of the medicine
understudy.
[0226] In yet another embodiment of the present invention relates to use
of fingerprint of contour and 3-D chromatograms as a basis for the
identification of chemical constituents to limit the scope of the
invention.
[0227] In yet another embodiment of the present invention relates to the
method having standard analytical parameters like Extraction with ethyl
alcohol, maintaining same run time 0-60 min, using same mobile phase
acetonitrile along with phosphate buffer having a pH in the range of
5.5-7.5, and a same UV-Visible Range of 200-800 nm.
[0228] In yet another embodiment of the present invention, a method uses a
standard analytical parameter like Extraction with same solvent ethyl
alcohol for all samples for the finger printing of a particular
therapeutic group of samples to make therapeutic generalizations.
[0229] In yet another embodiment of the present invention relates to a
method of fingerprinting for the adulterated food, drug and chemical
samples and to identify the pure and adulterated.
[0230] In yet another embodiment of the present invention relates to a
method of fingerprinting for the substituted food, drug and chemical
samples and to identify the pure and the substituted.
[0231] In yet another embodiment of the present invention relates to a
method of fingerprinting for the contradictual food, drug and chemical
samples and to identify the pure and the substituted.
[0232] In yet another embodiment of the present invention relates to a
method of fingerprinting for the commercial samples of food and drug and
to identify the pure and the substituted.
[0233] In yet another embodiment of the present invention relates to a
method of fingerprinting for the organic and organo-metallic constituents
in any type samples to identify the chemical constituents present in it
for various purposes of quality control and process standardization.
[0234] In yet another embodiment of the present invention relates to a
method of fingerprinting for the Allopathic, Ayurvedic, Homoeo, Siddha,
Unani, Chinese medicine, Tibetan and Kampo (Japanese) medicine samples
for the quality control and chemical and therapeutic standardization
[0235] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of variation of chemical
constituents in Naturally occurring samples and to identify and
standardize the chemical constituents in them.
[0236] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of variation of chemical
constituents in Naturally occurring samples and to identify and
standardize the variation in chemical constituents in them due to
geological and Ecological factors.
[0237] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of variation of chemical
constituents in Naturally occurring samples and to identify and
standardize the variation in chemical constituents in them due to
Genotypic and Phenotypic variation factors.
[0238] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of chemical constituents in
Synthetically prepared samples and to identify and standardize the
chemical constituents in them for chemical and therapeutic
standardization which ever is applicable.
[0239] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of chemical constituents in herbal
products of single and formulated medicine samples and to identify the
chemical constituents in them for chemical and therapeutic
standardization.
[0240] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of variation of chemical
constituents in biological samples and to identify and standardize the
chemical constituents in them.
[0241] In yet another embodiment of the present invention relates to a
method of fingerprinting for the study of variation of chemical
constituents in different brands of products of single and formulated
food and medicine samples and to identify the chemical constituents in
them for chemical and therapeutic standardization.
[0242] In yet another embodiment of the present invention relates to a
method of preparing a database giving many generalizations of the
therapeutic efficacy of a particular group of plants, classified as a
group for a particular disease or therapeutic classification.
[0243] In yet another embodiment of the present invention relates to a
method to develop fingerprinting and to categorize and quantify the
constituents of a medicine, based on polarity and conjugation from 3-D
and contour chromatograms.
[0244] In yet another embodiment of the present invention relates to a
method, which provides a barcode for the selected peak of a molecule
given in the image, wherein X--the retention time, Y--the wavelength,
R--the number of red pixels, G the number of green pixels and B the
number of blue pixels are the coordinates provided by the present
computer based (Microchip, Dongle switch, hardware and software locked)
software and is feed to any commercially available re-salable bar-coding
software resident in the proposed software, generates a barcode. Some
examples of images displaying the X--retention time, Y--wavelength,
R--number of red pixels, G--number of green pixels and B--number of blue
pixels the coordinates of a particular peak (s), which is specific to the
product and the barcodes thus, generated are enclosed.
[0245] In yet another embodiment of the present invention relates to a
method, to prepare a database of barcodes for the fingerprints developed
useful for all types of database applications.
[0246] In yet another embodiment of the present invention relates to a
method to generate display windows for all the samples the fingerprints
are developed. In the `display window` all details of the samples like
both 3-D and Contour fingerprints, the barcode, details of the origin
(Industry or Country), manufacturing date, date of expiry, reported
dosha, individual constituents used, their assay, batch number, lot
number, M.R.P and other information on the label), are displayed. When
the barcode on the label is shown to the vending machine, it will display
the attached display window. This helps to know the chemical and
therapeutic authenticity of the medicine being sold/purchased in all
types of regulatory and commercial applications.
[0247] In yet another embodiment of the present invention relates to a
method to attach the display windows with the respective barcodes,
facilitating to deal with display windows in all applications whenever
they are used as a source of data and information.
[0248] In yet another embodiment of the present invention relates to a
method to prepare a database of display windows thus generated and
attached to the respective barcodes, to use in the ENTERPRISE RESOURCE
PLANNING (ERP) and CUSTOMER RELATIONSHIP MANAGEMENT (CRM) applications
for all commercial networking transactions of the medicines and samples
for which the database was prepared.
[0249] In yet another embodiment of the present invention relates to a
method to prepare a database of barcodes and display windows and any
information, specially required for the regulatory authorities to control
the movement of the medicines in and out of the country.
[0250] In yet another embodiment of the present invention relates to a
method for chromatographic fingerprinting which enables to understand and
standardize the Physico-Chemical properties of the medicines like color
for the therapeutic standardization of the medicines and humors.
[0251] In yet another embodiment of the present invention relates to a
method for chromatographic fingerprinting which enables to understand and
standardize the Physico-Chemical properties like Taste (Rasa) like Sour
(Amla), Salty (Lavana), Pungent (Katu), Bitter (Tikta), Astringent
(Kashaya) of the medicines, for the therapeutic standardization of the
medicines and humors.
[0252] In yet another embodiment of the present invention relates to a
method for chromatographic fingerprinting which enables to understand and
standardize the Chemical properties of the medicines like Cold, Hot, Slow
in action, Sharp in action, Heavy, Light, Soft, Lubricated, Supple, Dry
(Guna's like Sheeta, Ushna, Manda, Teekshna, Guru, Laghu, Snigdha and
Rooksha as described in Ayurveda) of the medicines for the therapeutic
standardization of the medicines.
[0253] In yet another embodiment of the present invention relates to a
method for chromatographic fingerprinting which enables to understand and
standardize the Physico-Chemical properties of the medicines like
Potency, Metabolite formation after assimilation and Specific properties
like Charlotte of the molecules (Described as Veerya, Vipaka and
Prabhava) for the therapeutic standardization of the medicines and
humors.
[0254] In yet another embodiment of the present invention provides a
software based data processor of 3-D chromatograms and contour image of
an ingredient.
[0255] The method of the invention is described in steps with reference to
the accompanying tables, drawings, flow charts and examples, which are
provided to illustrate some of the embodiments of the invention, and the
same should not be construed as limitations on the inventive concept
embodied herein.
DESCRIPTION OF THE ACCOMPANYING TABLES AND FIGURES
[0256] The following examples are given by way of illustrations and these
should not be construed to limit the scope of the invention.
I. TABLES
[0257] 1. Table showing different philosophies and various terminology
used in different medicines [0258] 2. Table showing Relation of Humors,
Properties, and different parts of the human body--An Ayurvedic approach.
[0259] 3. Table showing Division in terms of the Macrocosm in Chinese
medicine [0260] 4. Table showing Division in terms of the Microcosm in
Chinese medicine [0261] 5. Table showing the relation of five natural
elements and their relation [0262] 6. Table showing the meaning of Yin
and Yang used in Chinese Medicine [0263] 7. Table showing the basis of
color for the therapeutic classification of the medicines [0264] 8.
Table showing the effect of different colors on different diseases
[0265] 9. Table showing Properties of the six tastes (Rasas in Ayurveda)
and their properties and efficacy [0266] 10. Table of Colors and The
Relation with Wavelengths. [0267] 11. Table showing the role of acidity
and alkalinity in human body [0268] 12. Table showing the comparison of
different analytical techniques being used for the finger printing and
chemical standardization. [0269] 13. Table showing the parameters used
for developing fingerprints of some of the medicines [0270] 14. Table
showing the therapeutic classification of medicines reported in the
proposed invention. [0271] 15. Table of medicines shown as thumbnails.
[0272] 16. Table showing the division of the fingerprint in to
therapeutic zone based on the conjugation and polarity.
II. FIGURES
[0273] FIGS. 1A & B shows the five basic elements in Chinese medicine and
the relationship between them. Imbalance (excess or deficiency) of any
one element leads to disturbance in other elements and becomes the root
cause of a disease. The health of human body is achieved by managing and
controlling the above eleiments in Chinese medicine.
[0274] FIG. 2 shows the effect of colors on the basic humors based on
which the medicines of the same colors were selected for vitiating the
corresponding humor. The color of a medicine is due to the chemical
properties of the constituents present in it, and thus indirectly the
chemical properties are used for the therapeutic standardization.
[0275] FIG. 3 shows the fingerprints of Shilajit of two different brands.
The chemical profile in the fingerprint shows the therapeutic efficacy
due to the presence of more number of molecules with wide conjugative
properties. The chemical profile varies with the age of the sample, it
spent in the earth, and the more it is old, the more it will be
therapeutically active and may depend on the place of collection and
purification process.
[0276] FIG. 4 shows the existing use of chromatographic fingerprints on a
label.
[0277] FIG. 5 shows chromatogram of Commercial Turmeric (Food).
[0278] FIG. 6 shows chromatogram of Furazolidine (Allopathic).
[0279] FIG. 7 shows chromatogram of Krimikutara Ras (formulation).
[0280] FIG. 8 shows chromatogram of Shilajit (good by efficacy).
[0281] FIG. 9 shows chromatogram of Shilajit (Poor by efficacy).
[0282] FIG. 10 shows chromatogram of Suryavarti (formulation).
[0283] FIG. 11 shows chromatogram of Tea (food).
[0284] FIG. 12 shows chromatogram of Trikatu (formulation).
[0285] FIG. 13 shows the fingerprints of all yellow medicines. Here the
fingerprint of Sandigdha Dravyas (a controversial drug) shows a clear
difference in appearance, making the identification more easy.
[0286] FIG. 14 shows the fingerprints of all medicines of PITTA HARA in
nature. The presence of constituents in zone-1 indicates the efficacy of
the medicine.
[0287] FIG. 15 shows the fingerprints of all medicines of KAPHA HARA in
nature. The presence of constituents in zone-2 indicates the efficacy of
the medicine.
[0288] FIG. 16 shows the fingerprints of all medicines of VATA HARA in
nature. The presence of constituents in zone-3 indicates the efficacy of
the medicine.
[0289] FIG. 17 shows the fingerprints of all medicines of PITTA KAPHA HARA
in nature. The presence of constituents in zone-1 and zone-2 indicates
the efficacy of the medicine.
[0290] FIG. 18 shows the fingerprints of all medicines of KAPHA VATA HARA
in nature. The presence of constituents in zone-2 and zone-3 indicates
the efficacy of the medicine.
[0291] FIG. 19 shows the fingerprints of all medicines of PITTA VATA HARA
in nature. The presence of constituents in zone-1 and zone-3 indicates
the efficacy of the medicine.
[0292] FIG. 20 shows the fingerprints of all medicines of TRI DOSHA HARA
in nature. The presence of constituents in all three zones indicates the
efficacy of the medicine.
[0293] FIG. 21 shows the fingerprints of Kali musali and Safed musali that
are used as tri-doshahara medicine.
[0294] FIG. 22 shows fingerprints of different samples of Citrallus
Colosynthis. The fingerprint shows the lack of some constituents due to
which this method is used for standardization of extraction process of
homoeo mother tinctures from plants.
[0295] FIG. 23 shows fingerprints of different samples of Holarrena
Antidyssentric collected from different places of the country. The
fingerprint shows the influence of ecological factors on the chemical
constituent of the plant material.
[0296] FIG. 24 shows the fingerprints of two samples of Beetle leaves from
different places. The flavonoids present in the time range of 30-40 min
shows the influence of genotypic, phenotypic variations and ecological
factors on the chemical constituents of the plant material.
[0297] FIG. 25 shows the satellite images of India. These satellite images
indicates that India has different tropical zones.
[0298] FIG. 26 shows the fingerprints of two formulations used as
cosmetics like Herbal head Bath powders.
[0299] FIG. 27 shows the fingerprints of TRIKATU of two different brands.
The difference in their assay may be due to variations in the constituent
elements of TRIKATU.
[0300] FIG. 28 shows the fingerprints of turmeric and its three different
commercial products. A common peak occurs at 20 minutes in all these
fingerprints.
[0301] (FIGS. 29 to 92 shows the finger prints of all the medicines
reported in Table 13)
[0302] FIG. 29 shows both fingerprints of whole plant of Abel moschus,
Moschatus medicum.
[0303] FIG. 30 shows both fingerprints of bark of Acacia suma.
[0304] FIG. 31 shows both fingerprints of leaflets of Acalypha indica.
[0305] FIG. 32 shows both fingerprints of leaves of Adhatoda vasaka
[0306] FIG. 33 shows both fingerprints of leaves of Adiantum caudatum
[0307] FIG. 34 shows both fingerprints of stem bark of Ailanthus excelsa
[0308] FIG. 35 shows both fingerprints of rhizome of Acorus calamus
[0309] FIG. 36 shows both fingerprints of big single cloves of Allium
porum
[0310] FIG. 37 shows both fingerprints of small cloves of Allium sativam
[0311] FIG. 38 shows both fingerprints of rhizome of Alpinia galanga
[0312] FIG. 39 shows both fingerprints of rhizome of Alpinia officinarum
[0313] FIG. 40 shows both fingerprints of rhizome of Alpinia speciosa
[0314] FIG. 41 shows both fingerprints of unprocessed raw fruit nut of
Areca catechu
[0315] FIG. 42 shows both fingerprints of milk processed nut of Areca
catechu
[0316] FIG. 43 shows both fingerprints of stem bark of Areca kateeh
[0317] FIG. 44 shows both fingerprints of Homoeo mother tincture of Arnica
[0318] FIG. 45 shows both fingerprints of whole herb of Bacopa monneri
[0319] FIG. 46 shows both fingerprints of stem bark of Berberis aristata
[0320] FIG. 47 shows both fingerprints of whole plant of Borrhievia
diffusa
[0321] FIG. 48 shows both fingerprints of big, ripped fruit of Capscicum
Annum linn.
[0322] FIG. 49 shows both fingerprints of big unriped, fruit of Capscicum
annum linn.
[0323] FIG. 50 shows both fingerprints of small, unriped, fruit of
Capscicum annum linn.
[0324] FIG. 51 shows both fingerprints of stem bark of Coscinium
fenestratum
[0325] FIG. 52 shows both fingerprints of root and leaf of Coccinidium
grandis
[0326] FIG. 53 shows both fingerprints of leaf of D actlylactinium
Aegyptium (erect)
[0327] FIG. 54 shows both fingerprints of leaf of Dactlylactinium
Aegyptium (prostrate)
[0328] FIG. 55 shows both fingerprints of leaf and bark of Diristachis
cineraria
[0329] FIG. 56 shows both fingerprints of fruit epicarp of Emblica
officinalis
[0330] FIG. 57 shows both fingerprints of formulation of a face pack
[0331] FIG. 58 shows both fingerprints of formulation of a face pack
[0332] FIG. 59 shows both fingerprints of root bark of Glycerrhzia glabra
[0333] FIG. 60 shows both fingerprints of powder of whole plant of
Glycerrhzia glabra
[0334] FIG. 61 shows both fingerprints of whole plant of Gymnema
sylvestrae
[0335] FIG. 62 shows both fingerprints of stem bark of Hollerona
Antidysentrica
[0336] FIG. 63 shows both fingerprints of root of Innula recemosa
[0337] FIG. 64 shows both fingerprints of flower of Michellia champaka
[0338] FIG. 65 shows both fingerprints of Leaf of Moringa olifera
[0339] FIG. 66 shows both fingerprints of homeopathic mother tincture of
Myrica cerefera
[0340] FIG. 67 shows both fingerprints of whole plant of Nahi axillae
[0341] FIG. 68 shows both fingerprints of stem bark of Oroxylum indicum
[0342] FIG. 69 shows both fingerprints of leaf of Ocimum sanctum
[0343] FIG. 70 shows both fingerprints of leaf of Pluchea lanceolata
[0344] FIG. 71 shows both fingerprints of stem bark of Picrorrhiza kurroh
[0345] FIG. 72 shows both fingerprints of leaf of Piper beetle.
[0346] FIG. 73 shows both fingerprints of seeds of Psoralia corilifolia
[0347] FIG. 74 shows both fingerprints of leaf of Raphanus sativus
[0348] FIG. 75 shows both fingerprints of root of Ricinus cummunis
[0349] FIG. 76 shows both fingerprints of stem and root of Rubia
cordifolia
[0350] FIG. 77 shows both fingerprints of root of Saussrea lappa
[0351] FIG. 78 shows both fingerprints of whole herb of Spheranthus
indicus
[0352] FIG. 79 shows both fingerprints of stem bark of Symplocus racemosus
[0353] FIG. 80 shows both fingerprints of fruit of Terminalia chebula
[0354] FIG. 81 shows both fingerprints of fruit of Terminalia bellerica
[0355] FIG. 82 shows both fingerprints of whole plant Trigonella faenum g.
[0356] FIG. 83 shows both fingerprints of stem and root of Tribulus
terrestrias.
[0357] FIG. 84 shows both fingerprints of leaves of Tylophora asthmatica
[0358] FIG. 85 shows both fingerprints of mother tincture of Homoeo
medicine Viburnum
[0359] FIG. 86 shows both fingerprints of Root of Withinia somnifera
[0360] FIG. 87 shows both fingerprints of rhizome of processed Zinziber
officinalis
[0361] FIG. 88 shows both fingerprints of powder of Avipattakara churna
[0362] FIG. 89 shows both fingerprints of an herbal formulation of
Kamaduga Ras
[0363] FIG. 90 shows both fingerprints of a Kumarayasava a herbal medicine
by fermentation process
[0364] FIG. 91 shows both fingerprints of an herbal formulation of
Mahalakshmi vilas ras
[0365] FIG. 92 shows both fingerprints of an herbal formulation of Suvarna
yogaraja Guggulu
[0366] FIG. 93 shows the fingerprint of Anandabhairavi Ras. Right clicking
on any particular peak, the image software will display the X Y, R, G and
B coordinates of the peak, which are used for bar coding. These
coordinates are shown inside a box (near the peak) and in the tool bar.
[0367] FIG. 94 shows the fingerprint of Krimikutara Ras. The image
software displays the bar code values of a particular peak.
[0368] FIG. 95 shows the barcode generated for Anandabhairavi Ras
[0369] FIG. 96 shows the barcode generated for Krimikutara Ras.
[0370] FIG. 97 shows the display window for Anandabhairavi Ras
[0371] FIG. 98 shows the display window for Krimikutara Ras
[0372] FIG. 99 shows how the network works in an Enterprise Resource
Planning and Customer Relationship Management applications networked
using the database prepared by the proposed method.
[0373] FIG. 100 shows a new chromatogram in the form of a colored bar
chart for the tender leaves of Azadiracta indica collected in February
[0374] FIG. 101 shows a new chromatogram in the form of a colored bar
chart for the medicine of Anandabhairavi Ras an herbal formulation.
[0375] FIG. 102 shows a new chromatogram in the form of a colored bar
chart for the medicine of Krimikutara Ras, an herbal formulation.
[0376] FIG. 103 shows the Pie diagram for the chromatogram of Azadiracta
indica
[0377] FIG. 104 shows the Pie diagram for the chromatogram of
Anandabhairavi Ras
[0378] FIG. 105 shows the Pie diagram for the chromatogram of Krimikutara
Ras
[0379] FIG. 106 shows the Pie diagram of vitiation disorders (dosha)
quantitative.
[0380] FIG. 107 shows the Pie diagram of vitiation disorders (dosha)
quantitative.
[0381] FIG. 108 shows the Pie diagram of vitiation disorders (dosha)
quantitative.
[0382] FIG. 109 shows the fingerprints as 3D and contour images of several
herbal medicines, which are fed into a database and are used for various
ERP and CRM applications.
[0383] FIG. 110 shows the fingerprints as 3D and contour images of several
herbal medicines, which are fed into a database and are used for various
ERP and CRM applications.
[0384] FIG. 111 shows the fingerprint of adulterated cosmetic samples as
3D and contour images.
[0385] FIG. 112 shows the fingerprints of Mother tincture as 3D and
contour images these can be used to find out the dilution of Mother
tincture.
[0386] FIG. 113 shows the fingerprints of isolated medicines and their UV
spectra as 3D and contour images.
[0387] FIG. 114 shows the fingerprints of allopathic medicines as 3D and
contour images.
[0388] FIG. 115 shows a diagram with operational sequence of the software
with various Functionality's.
[0389] The invention is described in detail below with reference to the
accompanying drawings, flow charts and examples, which are provided to
illustrate some of the embodiments of the invention, and the same should
not be construed as limitations on the inventive concept embodied herein.
Method of Chemical Standardization:
[0390] Hence unlike a method currently under use, where in a chromatogram
is given at a single wavelength, a novel method of chromatographic
standardization, finger printing and bar coding is proposed, using
contour and 3-D chromatograms. It provides the total chemical profile
(properties like polarity and conjugation, there in) of the chemical
constituents present in complex medicines like herbal medicines and
formulations or any medicine. Further, bar coding the finger prints thus
generated will provide many commercial features in dealing such medicines
using the ERP and CRM applications.
[0391] The existing method of TLC fingerprinting FIG. 4 being used as a
chromatographic finger print, is showing only an assay of the
constituents present in it. It is not providing any chemical property
like conjugation or polarity. Another method of fingerprinting by HPLC
shows a chromatogram at a single wavelength presented as a
"Chromatographic Finger Print" of the medicine. In this, a selected peak
is identified chemically, what it is by structure, using various other
analytical techniques like NMR, LC-MS and IR for structural elucidation.
So, the single chromatogram by it self is not able to say what the
efficacy of the medicine is, without the support of other costlier
analytical instruments. It will be highly impractical to use such costly
techniques for a complex herbal medicine and formulations prepared by
formulating various organic and inorganic medicines for a particular
therapeutic purpose.
[0392] The quality of any formulated medicine will depend on the process
with which it was made. This will be different for each pharmacy or
pharmacist. What actually needed for the quality control of herbal
medicines and formulations is a simple analytical method that can give
the number of constituents (qualitative and quantitative) present in a
single medicine or formulation, and the therapeutic efficacy of the
medicine under study. Hence, any method, which does not provide the above
information, is incomplete.
[0393] In the method of chemical standardization of the present invention,
the constituents were first extracted in to a suitable solvent. The
extract was subjected to separation into individual constituents on a
High Pressure Liquid Chromatograph under standardized analytical
conditions. The 3-D and contour chromatograms given by the instrument
were converted in to chromatographic fingerprint images. The images were
analyzed using image analysis software specially prepared for this work.
The out put data is interpreted for the said standardization. Detailed
description of the method is given in experimental description of the
method.
Method of Therapeutic Standardization:
[0394] The traditional therapeutic standardization is highly
individualistic by ability and perception of the doctor. A general
availability of such method will be practically difficult. But the
existing scientific scenario emphasizes that any method or mechanism
needs to be standardized, and reproducible. Hence, in the present method
of chemical and therapeutic standardization an instrumental method is
proposed which brings down the human factor. This is made possible by an
instrumental analytical technique, which explains about the chemical and
therapeutic efficacy of the medicines under study in a simple way. In a
most scientific and organized society of modern science, the knowledge of
assessing the therapeutic efficacy of the medicines should be explained
with rational justification rather than individual skills and abilities,
as they will differ from individual to individual and are
non-reproducible. The method of the invention envisages the same without
deviating from the traditional concepts.
[0395] As explained above if one can assess the therapeutic efficacy of
the medicine by the physico-chemical properties (Polarity and
conjugation), the activity of the medicines is understood thus achieving
the therapeutic standardization. In the present method, the conjugative
and polarity properties are taken in to consideration to assess the
therapeutic efficacy of a medicine.
[0396] In the ancient literature a clear classification of soils and
plants were given based on their physico-chemical nature and therapeutic
efficacy. The selection of medicines for a particular disease was done
based on the guidelines like color, texture, odor and physical
appearance. Table 8 of the effect of different colors on different body
parts shows how color was used for this purpose. The soil types and the
diversity of the drug action were also mentioned while selecting a
medicine. The effect of climate and its effect in the efficacy on the
drug plants were also clearly mentioned. Because the chemical
constituents present in the plant depends on these geological and
ecological variable factors, guide lines were laid down for the place of
collection, time (seasonal and daily) of collection, part of plant for
collection and age of plant for collection, required for a specific
therapeutic action.
[0397] Based on the generalia of the plants used for a common type of
diseases the plants were classified into 37 groups (Wealth of Susrutha,
K. H. Krishnamurthy, Indian Institute of Ayurveda, Coimbatore,
India--originally from Susruta Samhita sutrasthana 38). Thus, these
plants should contain the chemical constituents having similar
therapeutic efficacy on the reported disease.
[0398] When the fingerprints of the different classes were studied, some
common features are found about the therapeutic efficacies of the
medicines. The same efficacy was reported in the traditional literature
also. In other words, i.e. the experimental and reported results are
equal. Hence, studying different medicines, having different therapeutic
efficacy validated the method.
[0399] The FIG. 13 shows all medicines, which are yellow in color. In the
ancient literature of Ayurveda all these medicines were classified as
Haridra class, all the medicines being yellow in color like Haridra
(Turmeric). When the fingerprints are studied, it is found that all these
medicines are reported to be used as Kapha Hara, vitiation of disorders
related to mucogeneous constituents of the body. Hence, it is understood
that the color of the medicines has a direct relation with their
therapeutic efficacy. Rationally it is also true that the color and the
efficacy of the medicines are due to chemical constituents and their
physico-chemical properties.
[0400] The fingerprints of single medicines like Rubia cordifolia, Saraca
Indica, Picrorrhiza Kurro, Phyllanthus Niruri and Formulations like
Arogya Vardhini and Avipattakara Churna are presented in FIG. 14. The
molecules eluted in Zone 1 indicates the presence of Polar constituents
based on the elution pattern due the set analytical conditions. A general
tendency of this elution pattern for the medicines reported to be Pitta
Hara, confirms that high polar constituents act mainly as Pitta Hara.
[0401] The fingerprints of single medicines like Zinziber officinalis
(Processed), innula racimosa, Sausserea Lappa, Ocimum Sanctum, Glycerzia
glabra and Shilajit are reported to be Kapha Hara. The molecules eluted
in Zone 2 indicate the presence of Medium Polar constituents. A general
tendency of this elution pattern for the medicines reported to be Kapha
Hara confirms that medium polar constituents act mainly as Kapha Hara as
shown in FIG. 15.
[0402] The fingerprints of single medicines like Alpinia offinarum,
Ricinus communis, and Formulations like Suvarna yogaraja Guggulu,
Brihatvata chintamani with swarnamakshkam, Huthasana and Mahayogaraja
Guggulu are presented in this Figure. The molecules eluted in Zone 3
indicate the presence of very low or non-polar constituents, mostly oily
in nature, based on the elution pattern due the set analytical
conditions. It is observed that any medicine used for this disorder
contain or mixed with oils. Along with oily type of constituents, the
herbo mineral organo metallic molecules eluting in this zone are also
found Vata Hara. A general tendency of this elution pattern for the
medicines reported to be Vata Hara, confirms that low or non-polar
constituents act mainly as Vata Hara as shown in FIG. 16.
[0403] The fingerprints of single medicines like Azadiracta indica,
Curcuma longa, Hollarrheana Antidyssentrica, Berberis aristata, Psoralia
Cordifolia and Citrullus Colosynthis are presented in this Figure. The
molecules eluted in Zone 1 and 2 indicate the presence of high polar and
medium polar constituents. Thus, these medicines having the medium polar
constituents are found to be Pitta-Kapha Hara. This confirms that the
efficacies of the medicines are under stood by the polarity of the
constituents present in it as shown in FIG. 17.
[0404] The finger prints of the single medicines like Tribulus
Terrestrius, Moringa Olifera, Piper Beetle and formulations like Trikatu
indicate the presence of constituents in the Zone 2 and Zone 3 indicating
the efficacy as Kapha Vata Hara in nature, FIG. 18 explain the same.
[0405] The fingerprints of the single medicines like Bacopa monneri,
Oroxylum Indicum and formulations like Kanchanara Guggulu indicate the
presence of constituents in the Zone 1 and Zone 3 indicating the efficacy
as Pitta Vata Hara in nature. In a formulation called Anadabhairavi, even
though the efficacy reported is Pitta Vata Hara it is found Kapha Vata
Hara by finger printing. This indicates the artificial preparation of the
medicine was not successful to prepare a medicine of the required
efficacy. Hence, this method is useful in the process standardization of
the preparation of complicated formulations mentioned above. FIG. 19
indicate the same.
[0406] The finger prints of the single medicines like Allium Cepa,
Withinia Pubiscence (Red Seeds), Embalika Officinalis and formulation
like Mahalakshmi vilas ras indicate the presence of constituents in all
the three Zones of 1,2 and 3 indicating the presence of molecules of the
entire range of polarity. This indicates that they will be of Tri Dosha
Hara by efficacy. In the finger print of Mahalakshmi vilas ras the
presence of two similar type of molecules can be seen like isomeric in
nature. The Prabhava effect is understood in these type of medicines when
such type of isomeric (Geometrical and Chiral) constituents are present.
FIG. 20 shows the fingerprints of all medicines of Tri Dosha Hara.
[0407] The fingerprints of Kalimusali (Curculigo Orchioidis) and
Safedmusali (Asparagus Adescendens) indicate how two plants of different
family's were classified under same therapeutic group. The fingerprints
show similar constituents in all the three zones with little difference
in assay indicating the tri-doshahara property, as indicated in FIG. 21.
[0408] The fingerprints of a single medicine of two different sources like
Citrullus Colosynthis used in both Ayurveda and Homoeo are given. On
observation of the fingerprints, it is found to contain constituents of
three polarities, but mostly high polar molecules more in number. On
careful observation of the fingerprints, it is observed that the presence
and absence of molecule at 12 minutes is the only difference between both
the images. The taste of first medicine was very bitter when compared to
the second one. Thus using the taste, as a measure of the efficacy of the
medicines is also proposed, this was mostly used in the ancient
literature, as shown in FIG. 22.
[0409] The fingerprints of Hollarrena Antidysentrica, a medicine collected
from two different parts of the country has shown much difference in
their chemical profile. This indicates the influence of geological,
ecological, genotype and phenotypic and other variable factors on the
chemical constituents of the herbal medicines; this is illustrated by
FIG. 23.
[0410] A vast difference was seen in two samples of beetle leaves one from
Andhra Pradesh and another from Calcutta of India FIG. 24. This confirms
the role of ecological, genotypic and phenotypic variations in the
chemical constituents of plant parts.
[0411] In the FIG. 25 the Eco-regions, precipitation, Temperature and
Climate of India were shown to understand the role of seasons on the
ecology of the flora and fauna of it. The variations in the seasons will
have an impact on the chemical constituents of the herbal plants and
thereby medicines produced from them. This applies to the entire world
whenever an herbal plant is collected from different parts of the world.
[0412] The fingerprints of two formulations used as cosmetics like Herbal
head Bath powders are given. The fingerprint of the pure herbal material
is totally different from the adulterated one. The artificial detergents
and foaming agents eluted at 25 to 40 minutes are clearly seen in the
adulterated sample, they are highly basic and soapy in nature. This
supports that the method of the invention is useful for the regulatory
authorities to check the pilferage of traditional medicines with
adulterations and substitutions, as illustrated in FIG. 26.
[0413] The fingerprints of a formulation namely Trikatu of two different
brands shows difference in its assay. This may be due to usage of single
medicine(s) were used to prepare the formulations from different sources.
The present method shows the extent they are different qualitatively and
quantitatively, facilitating to prepare standardized medicines and
extracts of herbal medicines as shown in FIG. 27.
[0414] The fingerprints of a single medicine of three different brands of
the same food material like turmeric is given in FIG. 28. In the finger
print of the natural turmeric it is observed that the yellow curcumin
molecules eluted at 20 minutes. The same molecules are seen in all the
brands commonly. The difference in the profile is the commercial samples
are because they were prepared processed (Boiled) turmeric rhizomes and
the natural is from unprocessed (Un-boiled) rhizomes.
[0415] FIGS. 29 to 92 gives the fingerprints developed for various
medicines and the image parameters (Elevation and rotation) used for the
3-D and Contour chromatograms of all the medicines given in table 13. In
table no 14, the medicines analyzed were classified on the basis of
therapeutic efficacy. The analysis of fingerprints of the respective
medicines using the proposed software will support the claim of utility
of the method of the invention for the therapeutic standardization.
[0416] This confirms that this method is useful in many purposes of
dealing the traditional medicines. It is useful for modern medicines also
to understand their therapeutic efficacy in traditional terms.
Method of Bar Coding, Enterprise Resource Planning (ERP) and Customer
Relationship Management Application (CRM) Application
[0417] In the present method the software analyzes the image and can
display the coordinates X retention time, Y wavelength, R number of red
pixels, G number of green pixels and B number of blue pixels by the
present computer based (Microchip, Dongle switch, hardware and software
locked) software for a contour chromatogram, for a particular peak which
is specific to the product. When this data is transferred/feed to a
resident in built re-salable bar-coding software, automatically an
optional pixel value of a peak in the image, it generates the barcode
having attached the `display window` with all details of the product
under study.
[0418] The method of the invention facilitates to barcode any number of
constituents present in a chromatographic finger print of a herbal
medicine, using the X retention time, Y wavelength, R number of red
pixels, G number of green pixels and B number of blue pixels as the
coordinates provided by the present computer based (Microchip, Dongle
switch, hardware and software locked) software and the values of each of
the constituents provided by the present software. These factors will be
representing the chemical and therapeutic efficacies of the constituents.
Hence instead of a mere catalogue number presently used for the bar
coding, a novel method of bar coding is proposed where in, the coordinate
values of the constituent will be displayed along with other details.
Thus, the barcode and the coordinates-will speak about the chemical and
therapeutic properties of the product.
[0419] It becomes a tool for the regulatory authorities like Drug
Controller, Public analysts, Food adulteration enforcement authorities,
Forensic and Customs and Central excise departments for the regulation of
the herbal Products. The fingerprint of the medicines should be printed
on the label and should be tallied when it is checked. This also helps to
monitor the various other brands of a same medicine for an industry to
monitor. FIGS. 93-94 shows how the software gives the coordinates for a
selected peak of the image. These values will be given for a barcode to
be generated. FIGS. 95, 96 are the barcodes thus generated. FIGS. 97, 98
show how a display window will be for an herbal medicine with all label
details. The barcode will be able to show when the display windows when
they are attached to the barcodes of the respective products. When a
large database is prepared for the products and made available in the
network, any ERP and CRM application can use for any required purpose by
network. FIG. 99 shows how the network woks in an ERP and CRM
applications networked.
Various Steps Involved in the Present Invention
[0420] In the present method of analysis a Validated High Pressure Liquid
Chromatograph equipped with a Binary Gradient system of pumps, a Photo
Diode Array Detector (PDA), and a Software based data processor for
presentation of the chromatograms was used. After the complete elution of
all ingredients, the 3D and contour chromatograms (having the information
of the UV-Visible Spectra, absorbance and retention times of all the
constituents present in a single medicine or formulation) were converted
into an image and proposed as a finger print. This enjoys the merit of
not requiring any internal or external standard sample for an authentic
qualitative and quantitative analysis of all the ingredients present in a
medicine, unlike in the present method of analysis of medicines.
[0421] Experimental Description of the Method:
[0422] The proposed method is described in 4 steps with reference to the
accompanying drawings, flow charts and examples, which are provided to
illustrate some of the embodiments of the invention, and the same should
not be construed as limitations on the inventive concept embodied herein.
[0423] The entire method is described in the steps mentioned below:
[0424] Step 1: Selection of medicines and extraction of the constituents
[0425] Step 2: Separation of the constituents into individual
constituents and generating and converting the 3-D and Contour
Chromatograms in to finger prints. [0426] Step 3: Analysis of the
fingerprints using the software developed. [0427] Step 4: Interpretation
of data Description of the Present Method of Analysis Step 1: Sample
Preparation
[0428] Constituents are extracted from the medicines using ethyl alcohol,
selected based on the chemical nature (polarity) of the sample. When the
pH of the aqueous alcohol extract is varied, the extraction of
constituents also has varied. The basic pH has extracted more number of
constituents than acidic pH. Suitable pH was selected for extraction of
different medicines and the same was maintained using buffers. The role
of acidity and alkalinity was taken into consideration while selecting
the pH for extraction.
Step 2
Experimental Work Done on the Instrument:
[0429] The extract was subjected to separation analysis, using
High-Pressure Liquid Chromatographic (HPLC) instrument. In the present
method of analysis, a Validated High Pressure Liquid Chromatograph
equipped with a Binary Gradient system of pumps, a P
hoto Diode Array
Detector (PDA), and a Software based data processor, for the preparation
of the chromatograms were used. A known amount of the sample (say 20 ul)
of extract is injected into rheodyne injector (fitted with 20 ul loop).
Elution of the sample was performed with suitable time programmed
gradient system of mobile phase at a fixed flow (1 ml/min). Care is taken
that no part of the sample is left in the column un-eluted. The following
analytical conditions set for the analysis. [0430] a. A reverse phase
column was used along with a time programmed gradient elution of an
aqueous phosphate buffer (In the pH range of 5.5-7.5) and a non-aqueous
solvent (acetonitrile or methanol) is used as eluent based on the
chemical nature of the sample under analysis. [0431] b. A wave length
range of 200 to 800 nm was used for the PDA detector and the run time is
fixed based on the time program. [0432] c. The time program, which
changes the concentration of non-aqueous solvent like Acetonitrile 0-100%
of organic solvent, is used in the instrumental parameters existing in
the instrument.
[0433] The instrument was triggered for the analysis after injecting the
sample into the injector. The run was stopped whenever the analysis is
completed or the instrument will stop the run automatically after the
entire time program is completed.
[0434] In the three types of display of data, the chromatograms, one
window displays chromatogram at a selected wavelength, in another it
displays the contour chromatogram which displayed the retention time (run
time) of the analysis on X-axis and the wavelength range on Y-axis. In
another window, it displayed the 3-D chromatogram of the sample where in
it displayed the retention time (run time) of the analysis on X-axis, the
concentration range on Y-axis and the wavelength range on Z-axis. The 3-D
and contour chromatogram thus developed by the system was converted into
an image.
[0435] The images thus generated were analyzed by the proposed software,
which provides a novel chromatogram and the qualitative and quantitative
analytical data of the in-gradients present in the medicines. The pixel
values represented by different colors from Violet, Indigo, Blue, Green,
Yellow, Orange and Red attributed as a measure of the concentration
(quantitative) of the constituents proportional to the color. Extracting
the individual colors mentioned above and shows in separate widows for
each color. This is the basis of chemical standardization. Some
chromatograms thus generated are shown in FIGS. 100-102.
[0436] The chromatogram thus provided by the software gives the
information of conjugative (shown by the UV-VIS absorbance) and polarity
properties of the individual constituents together. The image is divided
into three zones representing, Zone 1 (High polar zone), Zone 2 (medium
polar zone) and Zone 3 (low or non polar zone) scaled by retention times
based on the elution pattern, depending on the column used and the mobile
phase. Reversing the analytical conditions can reverse the elution
pattern.
[0437] The 3-D chromatograms of the medicine are analyzed using all its
three dimensional properties of the said image. If the 3-D chromatogram
is considered as a cap with a hood the matching of the entire cap 3
dimensionally, with another sample of different qualitative and
quantitative properties, the extent it matched will be presented as an
analytical report qualitatively and quantitatively. Here the hood of the
cap is compared to the peak of the molecule at a particular wavelength. A
sample with more number looks like a cap with many hoods. Thus the
matching of the three dimensional coordinates provides a foolproof method
of comparison and analysis. The coordinate it matched gives qualitative
and the extent it matched gives the quantitative data of the sample
understudy. This is made possible by special software prepared for this
purpose. This becomes an ultimate method of quality control.
[0438] The interaction of the polarity of the molecules being separated,
the polarity of the stationary phase used and the polarity of the mobile
phase used for the elution of the sample controls the elution pattern of
the molecules. The resultant inter action of all the three and other
related parameters like temperature etc., decides the elution pattern and
order of elution of the constituents based on their polarity. Thus, in a
medicine all the polar molecules will elute in first `Zone 1` (Polar zone
of the image), all the medium polar molecules will elute in `Zone 2`
(Medium polar zone of the image) and all the low polar or non polar
molecules will elute in `Zone 3` (Non polar zone of the image). When the
molecules eluted in these three zones of many fingerprints, many
generalizations were made regarding the chemical and therapeutic efficacy
of the medicines. This is another basis of therapeutic standardization.
The zones are shown marked in the FIGS. 103-105.
[0439] Thus, the chromatogram gives the information, how it is going to
act chemically and so therapeutically. When the individual constituents
present in each zone and represented graphically or by any means of data
presentation, the total constituents of the respective zone gives the
percentage it is going to act on the particular dosha. Thus, the data
explains how it (medicine) is going to act therapeutically on the
vitiation of each dosha collectively based on the qualitative and
quantitative properties of the constituents present in the medicine. For
example if the medicines has 30% constituents in high polar zone (the
pixel quantities of various colors like green, yellow, orange and red of
a specific zone as quantities) 70% in medium polar zone it can be
represented as a medicine acts 30% on pitta and 70% on kapha, as the
colors represent different concentrations in the fingerprints. Hence a
medicine can be assessed as of Pitta-Kapha Hara (30-70%). Thus, the
vitiation of doshas is quantified. This helps the doctor to under stand
the efficacy of the medicines and decide his dosage. Some example Pie
diagrams are given in the FIGS. 106-108.
[0440] 3-D and contour Spectra of the reported herbal medicines were
developed using the reported analytical conditions. The thumb nail view
of the medicines shows how the finger prints can be handled by a software
as it is done in the software used in handling the human fingerprints.
All the features like searching the similar and compare the similar
fingerprints etc., can be done by inserting the necessary software
features. In FIGS. 109-114 the thumbnails of the fingerprints for various
medicines are given. The lists of medicines shown as fingerprints were
shown in table 15.
[0441] Step 3
[0442] Analysis of the Image Using Image Analysis Software:
[0443] After the complete elution of all ingredients, the 3D and contour
chromatograms were converted into images and proposed as fingerprints.
This enjoys the merit of not requiring any internal or external standard
sample for an authentic qualitative and quantitative analysis of all the
ingredients present in a herbal medicine, unlike in the analysis of a
synthetic medicines.
[0444] After developing the image of the 3-D and contour chromatograms of
the medicine under study, (Hence forth called as Chromatographic finger
print) it is analyzed by the soft ware proposed for the analysis of
various colors representing the Qualitative and Quantitative properties
of the constituents present in it.
[0445] Scientifically, an image cannot become an analytical data, hence a
computer based image analysis software (software and hard ware protected)
has been developed to analyze the image and give proportional
concentrations of the ingredients of the medicine under study. Based on
the colors of the constituents present in various retention times and
pixel values of the image.
[0446] Now the images of the fingerprints were given to Image Analysis
software as said above. The analysis of various colors was done by which
the constituents will be represented as peaks of the chromatogram and
thus providing a novel presentation of chromatogram in the form of a
colored bar chart. It shows the number of compounds and their conjugative
properties UV-VIS absorptive property of all of the constituents eluted.
The detailed description of the process involved in the analysis of the
image is discussed in the technical features of the software.
[0447] The bar chart type of chromatogram thus developed gives a
chromatogram having a scale of Retention time (0-60) on the X-axis and
wavelength in the range of 200-800 nm, on the Y-axis. It gives the number
of pixels occupied by each of the colors of each in-gradient in the
image, facilitating the qualitative and quantitative analysis of the
individual constituents present in it. Thus, the chromatogram generated
is presenting the number of constituents present in a medicine and their
UV absorption range with quantity of pixels proportional to the
concentration of the molecules.
[0448] When the image is divided into, three zones based on the elution
pattern of the molecules and the changing polarity of the mobile phase.
The Zone 1 is polar zone as the column used is a reverse phase column,
the Zone 2 is medium polar zone where in the medium polar molecules are
eluted and finally the Zone 3 is low or non polar zone as the non polar
and very low polar molecules will elute in this zone. Thus, the molecules
eluted in zone 1 will be polar, the molecules eluted in the zone 2 will
be of medium polar in nature and the molecules eluted in the zone 3 will
be of very low or non polar in nature. Hence, the three zones of the
images will give the polarity of all the constituents eluted.
[0449] Based on the polarity of the molecules eluted, the medicines are
classified according to traditional system of therapeutic efficacy where
in the polar compounds are found to be Pitta Hara, the medium polar
compounds are Kapha Hara and the low or non polar compounds are Vata
Hara. This is the basis of therapeutic standardization of the medicines.
The polarity of the constituents is compared to a continuous spectrum of
radiation, where in the dosha is classified as acute to chronic of each
dosha. The starting of the zone will be acute and the end of the zone
will represent the chronic. Thus, the compounds present in the said zone
will act on the said intensity of the disease.
[0450] Table 16 shows division of the fingerprint in to different
therapeutic zone based on the color of absorption and polarity. The scale
on X-axis shows the scale of polarity of the molecules based on the
polarity of the mobile phase and Y-axis shows the range of wavelength
(200-800 nm) absorbed. Based on the reported therapeutic efficacy in the
literature based on the physico-chemical properties (Color and Chemical
properties) and the experimental the therapeutic efficacy of various
medicines was standardized. Some deviations were found which could be due
to the effect of variable environmental factors influencing the chemical
constituents of the medicines.
[0451] Thus, the method will help to know the therapeutic efficacy of the
medicines under study. Hence, the proposed method will become a novel
visual proof for the understanding the therapeutic efficacy of the
medicine reported or new, single or formulated.
[0452] The analysis of the images was done using software developed for
this purpose. The details of the software is given in the release notes
and FIG. 115
[0453] Step 4:
[0454] Interpretation of the Data
[0455] The fingerprints generated are analyzed for their chemical and
therapeutic properties. The basic features in a fingerprint are found to
be
[0456] 1) the zone of the polarity in which the constituents have eluted;
and
[0457] 2) the conjugative properties of the individual constituents
present.
[0458] The polarity of the column is fixed. It is a normal phase or a
reversed phase stationary phase. In the normal phase column, stationary
phase will be polar and in a reverse phase column, the stationary phase
will be non-polar. The extent of polarity of the stationary phase varies
from brand to brand even in same type of reverse phase or normal phase
column. The polarity of the stationary phase will be controlled using the
polarity of the mobile phase, additives like buffers and pH. When the
polarity of the mobile phase is varied constantly in the increased or
decreased order, on a reverse phase column, the constituents present in
the sample will elute in the same order, i.e., the high polar
constituents will be eluted by the high polar mobile phase, the medium
phase mobile phase will elute the medium polar constituents and the
non-polar constituents will be eluted by the non polar or low polar
mobile phase. The most preferred pattern is to change the polarity of the
mobile phase either increased or decreased order of polarity such that no
constituent of any polarity will be left un-eluted from the column thus
achieving total elution. Thus by controlling the polarity of the
stationary phase, polarity of the mobile phase will be managed to bring a
required effect on the polarity of the constituents to achieve separation
of required order of elution.
[0459] The order and properties of polarity and elution in the case of
normal phase columns are applicable as in the case of reverse phase
column but reverse to the reverse phase column. The non-polar
constituents will elute first, followed by polar constituents, based on
the order of polarity of the mobile phase used for elution.
[0460] Thus in the present elution also the elution of the constituents is
controlled and driven in the required pattern by controlling the polarity
of the mobile phase and the order of changing it in an orderly way.
[0461] Mostly the elution of the samples were done from high polarity
mobile phase to low polarity mobile phase. Thus in the finger prints the
constituents present in the first zone (Zone-1) will be of high polar in
nature. The same pattern applies to the other zones, the medium polar
constituents eluted in the medium polar zone (Zone-2) and the low or
non-polar constituents eluted in the non-polar zone (Zone-3). This
pattern reverse when a normal phase column is used due to its elution
property as described above.
[0462] Most of the high polar molecules will be highly reactive
chemically, thus biologically. When they enter the first part of the
digestive system mouth, they will immediately start acting on the
biological system and the enzymes present there. Then the constituents
will enter the stomach and intestine where they will under go different
changes (Post assimilation effects, Vipaka in Ayurveda) due to the
digestive juices and their enzymes present in the part. In the process of
absorption the moment the molecules of high activity (high polar) will
immediately start interacting with the biological system and show their
therapeutic properties. This can be compared that in Ayurveda, the
intestinal part of the human body is classified as Pitta zone, where the
high polar molecules are playing a major role. The heat causing mechanism
will play an important role in the diseases and biological mechanisms
related to. It indirectly indicates the molecules of high reactive, the
high polar molecules.
[0463] After the absorption, the blood with all the absorbed constituents
will carry them to heart and the parts related to it. Then the blood will
be sent to different parts of the body. In Ayurveda, the upper portion of
the human body is defined as the Kapha zone, where the cold mechanism
will be playing an important role. Thus, the molecules of medium polar
molecules will play an important role in the mechanisms related to this
zone.
[0464] The low polar and non-polar constituents will be able to enter to
the human body only through blood transfer, Thus the body organs where
the mechanism of availability of the chemical constituents is only by
blood will be coming in the last category of the polarity. The non-polar
oils, fats and other such molecules and mechanisms in the human body are
classified as Vata disorders and all such disorders are cure using the
same type of materials.
[0465] The low and non-polar constituents will be eluting in the last zone
of the fingerprint. Thus, this zone (ZONE-3) is considered as Vala zone.
Thus the basic humors of the molecules are able to be identified as per
their polarity which facilitates to know on what disorder (dosha) it is
going to act upon. Thus, the present method is useful for the therapeutic
standardization of the medicines.
[0466] The image was divided in to three zones on X and Y-axis. The
conjugative property (Absorption of a particular wavelength of radiation)
is taken on Y-axis and polarity is taken on the X-axis as the elution of
the constituents is controlled using the polarity of the mobile phase
composition. Now as reported in literature the Y axis is scaled as per,
the therapeutic efficacy based on wavelength (color). The entire image is
divided in to six chambers where in the chemical constituents have a
specific conjugative and polarity property. This in turn is proportional
to the therapeutic efficacy of the constituents in the chamber. Thus,
when a medicine is fingerprinted, based on the color represented for the
absorption of a specific wavelength and having a specific polarity, the
total colors in that zone is calculated and interpreted for the
therapeutic efficacy of the constituents present in it. Thus, the
holistic therapeutic standardization and chemical standardization is
achieved using this method. A schematic representation is given in table
15, showing the relation of conjugation and polarity to therapeutic
efficacy of the different constituents present in a medicine.
[0467] When the 3-D chromatograms of the medicine will be analyzed using
all its 3 dimensional properties of the said image. If the 3-D
chromatogram is considered as a cap with a hood the matching of the
entire cap 3 dimensionally, with another sample of different qualitative
and quantitative properties, the extent it matched will be presented as
an analytical report qualitatively and quantitatively. Here the hood of
the Cap is compared to the peak of the molecule at a particular
wavelength. A sample with more number will like a cap with many hoods.
Thus the matching of the three dimensional coordinates will provide a
foolproof method of comparison and analysis. The coordinate it matched
will give qualitative and the extent it matched will give the
quantitative data of the sample understudy. This is made possible by
special software prepared for this purpose. This becomes an ultimate
method of quality control.
[0468] But any method without quantification will be of no use. Hence, the
total colors of the constituents in the image of a particular zone are
considered as a representation of the amount of the polar constituents
present in the medicine. Thus the total constituents present in the
Zone-1 Pitta zone, Zone-2 Kapha zone, Zone-3 Vata zone are present in the
form of a Pie diagram which represents the ratio of the efficacy of the
medicine on each of the disorder. Thus, medicines having constituents in
the order of 50:20:30 will be medicines of Tridoshahara of the order of
50%: 20%: 30%. This was done using the software developed. Thus, the
therapeutic efficacy is standardized quantitatively. The increase or
decrease of any one or two of the other doshas can be done by formulating
medicine by adding other medicines and prepare a suitable formulation
needed to cure a specific individual.
[0469] The chemical standardization was done using the software by
quantifying the individual constituents based on the colors denoting the
concentrations of the in-gradients. The range of the wavelength that a
molecule absorbed denotes the conjugative properties.
[0470] As described in the traditional standardization methods the colors
of the medicines were standardized based on their colors and their
therapeutic efficacy. It applies even in the case of any molecules. The
Table 8 of colors and their efficacy will explain how colors were used to
standardize the efficacy of the medicines. The colors of the molecules
can be understood by their absorptive properties of the radiation of the
Uv-Vis range of radiation. In the Table 10 of colors and the relation
with wavelengths, the colors of the medicines and their characteristic
wavelengths are given. Based on the structure, functional groups,
conjugation, and the extent of unsaturation will influence the wavelength
of absorption (absorbance maxima) of the molecule. The more the molecule
is conjugated the longer the wavelength of absorption will be. Hence, the
UV-VIS absorbance of any molecule is widely used in the qualitative and
quantitative properties of the constituents.
[0471] The colors and the therapeutic efficacious of various medicines
were given in the ancient literature. The colors of the molecules are due
to a specific chemical nature of the molecule. The colors of the flames
were used for the quality control of metals and related products, which
involves the basic spectrophotometric principles. Thus, study and
understanding of the interaction of the electromagnetic radiation will be
useful to study the chemical nature and thus the therapeutic efficacy of
the medicines. The same principle has been used in the present
spectrophotometric method of fingerprinting and standardization. In other
terms an existing concept has been presented in the form of a novel
analytical method, removing the error of human factor. All the medicines
for which fingerprints developed were given in table of therapeutic
efficacy of the medicines were given in table 14. The technical details
of the software are given in the release notes of the software.
Release Notes for the Software Proposed
I) System Requirements (Minimum)
[0472] a. Processor: Pentium II or higher [0473] b. OS: Windows 95,
Widows 98, Win NT 4.0 and Linux [0474] c. RAM: 64 MB or higher [0475]
d. Monitor: 14'' Color Monitor (1024.times.768) or higher [0476] e.
Software: Java Development Kit (JDK 1.2.X) II) The Operational Mechanism
of the Software:
[0477] The various operational mechanisms are described below: operational
sequences with various functionality are shown in FIG. 115.
Title of the Software: RAINBOW (An Image analysis software for
chromatographic fingerprints)
[0478] This software is developed for the chromatographic fingerprints and
microscopic images. [0479] 1. It is GUI (Graphical User Interface) based
software. [0480] 2. The software is designed to analyze any kind of
image particularly for the analysis of chromatographic fingerprints.
[0481] 3. The reports are given in form of graphs. [0482] 4. Life Cycle
a. In put: Image b. Processing: [0483] Analysis involves [0484]
Extracting Colors (Standard 7 colors and some of their different shades)
[0485] Resizing, Deviding in to 3 zones at 20 minutes interval [0486]
Graphing (Bar and Pie graphs) [0487] Bar-coding [0488] Standards
Followed for extracting the colors:
[0489] The software extracts eight colors viz. Red, Green, Blue, Yellow,
Cyan, Magenta and Orange.
[0490] Any color is not absolute. It is mixture of the following shades of
the colors present before and after it, they vary between a range of
values. The range for the colors used to identify as the colors given
above the respective values are taken from the international standard
256-color scale. The values used in the present software are:
TABLE-US-00001
Red Blue Green
For Red color
200-255 0-64 0-64 and
192-200 0-64 0-32
For Green color
0-64 0-48 200-255
0-65 0-64 65-191
For Blue Color
0-96 200-255 0-191
[0491] Similarly, other colors were taken as standards for the extraction
of colors. (These standards are exclusive for the present software
requirements and are modifiable if required)
[0492] While image is analyzed, the software reads the image pixel by
pixel and reads and extracts the color according to the color standards
designated, stores and transfers them for further display as bar graphs.
c. Output:
Reporting
[0493] 1. By Graphs [0494] 2. By saving data like images, graphs,
deviding the image display into three zones [0495] 3. By displaying the
`X` (Retention time or Pixel value of the image), Y (Wave length or
absorbance of the images of contour and 3-D chromatograms respectively),
R (Red color), G (Green color) and B (Blue color) coordinates. [0496] 4.
By transferring these values to an in-built bar-coding software to
generate a bar code. d. User Interaction:
[0497] User is allowed to interact with the product in various ways.
[0498] 1. Inputing the desired image (one or more) [0499] 2. Resizing
the image to desired size and analyzing it. [0500] 3. Saving the image,
resized image, and graphs to it. [0501] 4. Printing the image, resized
image, and graphs to it. III) Technical Features of the Software [0502]
1. It is software entitled `Rainbow` [0503] 2. A software with a facility
of opening chromatographic fingerprint images in different Formats
(extensions) like BMP, JPEG, TIF, GIF from the file folders and analyze
it for different colors present in the image with single pixel
sensitivity. [0504] 3. A software with a facility of display of the
pixel information in the form of 1.a graph having a scale of X (0-(min.
time scale) and Y (200-800 nm) coordinates and 2. a Pie diagram with
individual values of each peak (Automatic and Manual) in two separate
columns beside the graph. [0505] 4. Software with a facility of printing
all the data generated after analysis using PRINT Icon. [0506] 5. A
software with a facility of changing the page setup for printing using
PAGE SETUP Icon [0507] 6. A software with a facility of selecting a part
of the image and analyze using RESIZE Icon. [0508] 7. A software with a
facility of opening any number of image analysis windows for different
images, and display of status in WINDOW icon. [0509] 8. A software with
a facility of dividing the image in to three Zones at 20 min interval,
using ZONE icon. [0510] 9. A software with a facility of inverting the
selected image using INVERT icon. [0511] 10. A software with a facility
of switching over to Notepad, Word pad and MS Word, using EDITOR icon.
[0512] 11. A software with a facility of operational information about
various features of the Software using, the HELP icon. [0513] 12.
Software with a facility of saving the data generated using SAVE AS icon
as. JEPG file format. IV) Installation Instructions for the Software:
a. Installation Procedure of Java 1.2.x Soft Ware Platform on Which the
Present Software Works. [0514] Explore the Java CD-ROM [0515] Double
click on the jdk1.2.0/jdk1.2.1/jdk1.2.2 setup icon [0516] The setup will
extract the files and conforms from the user whether to load the software
in the system. [0517] On click, `yes` it asks for the directory into
which it should install the files. [0518] By default, c:\jdk1.2
directory will be shown. [0519] If you want to install in "d" drive,
change the directory and Install the software. [0520] Once the
installation is completed go to c: and open the file named
`autoexec.bat`. [0521] Give the following path in the autoexec.bat file.
[0522] Open auto exe. Bat and write as follows [0523] Set
path=d:\jdk1.2\bin: % path % [0524] Setup class
path=d:\jdk1.2\lib\classes.jar; % classpath % Reboot and Use b.
Installation of Image Analyzer Software Proposed [0525] 1. Copy the
folder of the image analyzer software from the CD on to the system in the
desired directory. [0526] 2. Explore the batch file form the software
folder into which image analyzer software was copied. [0527] 3. Right
click on it and click on `send to desktop as short cut` [0528] 4. A `MS
dos` iconic short cut appears on the desktop. Right click the icon and go
to properties, select program tab and check on the `close on exit check
box`, convert window status `To minimized`. [0529] 5. Apply and close.
[0530] 6. Now the image analyzer software is ready for use. Double click
on the image analyzer Icon and it starts working. [0531] 7. In the
opening window, a box with `CSIR` will open where in the pass word `dvk`
should be typed. [0532] 8. Click the arrow mark (hand) on the right down
corner of the opening image to open the Software. [0533] 9. Open the
directory of the images of contour images without scale and select the
image to be analyzed. The image will be shown on the image window.
[0534] 10. Click on the RED analytical window marked with red boarder. A
PIE diagram will be displayed along with a chromatogram with retention
time on X-axis and nanometers on the Y-axis. [0535] 11. For constituents
of lesser concentration click on the Green, Yellow and Orange colors. The
Other colors are mostly the base line or less than that hence can be
ignored. [0536] 12. The details of using the other features of the
software are given in the help menu of the software including the various
features and applications of the software. V. Known Bugs:
[0537] Not found
VI. Abbreviations Used:
[0538] a. JDK: Java Development Kit [0539] b. Con: Contour Chromatogram
[0540] c. 3-D: 3-Dimensional Chromatogram [0541] d. WOS: Without Scale
[0542] e. X: Represents the Retention Time of the chromatogram [0543] f.
Y: Represents the absorbance in the 3-D chromatogram and wave length
range in contour chromatogram [0544] g. R: Intensity of red color at a
particular pixel position [0545] h. G: Intensity of green color at a
particular pixel position [0546] i. B: Intensity of blue color at a
particular pixel position VII. Meaning of the Various Icons and
functions
[0547] a. PRINT icon will facilitate in printing all the data generated
after analysis.
[0548] b. PAGE SETUP icon will facilitate in changing the page setup for
printing.
[0549] c. RESIZE icon will facilitate the selection of a part of the image
and analyze the selected part of the image.
[0550] d. WINDOW icon will facilitate in opening any number of image
analysis windows for different images, and display of status in
[0551] e. ZONE icon will facilitate in dividing the image in to three
Zones at 20-min interval.
[0552] f. INVERT icon will facilitate in inverting the selected image.
[0553] g. EDITOR icon will facilitate in switching over to Notepad, Word
pad and MS Word.
[0554] h. HELP icon will facilitate in the operational information about
various features of the Software usage.
[0555] i. SAVE AS icon will facilitate in saving the data generated in a
*.JPEG file format.
VIII. Constraints:
[0556] a) The present software works only for contour chromatograms
without scale.
[0557] b) The scale on X axis is in 1-(of "minutes" representing retention
time of the contour chromatogram
[0558] c) The scale on Y-axis is 200-800 nm representing the range of
wavelength under which the analysis is conducted.
[0559] d) The Image developed has to be resized using imaging software to
match the run time and wavelength range on X and Y-axis.
[0560] e) The images after analysis will be saved only in JPEG format
without scale.
[0561] f) The clip images should be stored with an extension of the
co-ordinates i.e. X1 and Y2.
Main Advantages of the Present Invention are:
[0562] 1. The contour chromatogram of the medicine becomes a Fingerprint
of it. Because it contains the UV-Vis spectrum band with concentration of
the ingredients along with the polarity of the molecule. The fingerprints
developed for a same medicine extracted under different pH value helps to
understand the drug release in the intestine system at different pH
values thus facilitating the pharmacodynamics of the medicines under
study. [0563] 2. The spectral bands of all the constituents are given in
a single picture assessing the medicine about its therapeutic properties
and nature, very easy. [0564] 3. The 3-D Chromatogram becomes a photo of
all the UV-spectra of all wavelengths of each constituent in a single
picture indicating the chemical (conjugative and polarity) property of
the molecule eluted. [0565] 4. A database of the fingerprints of various
herbal medicines available in the country useful for Quality control,
Forensic and customs departments to control the use and misuse of the
herbal medicines at the public interest. [0566] 5. The database also
gives information about the medicinal value of the various medicinal
plants of the country (therapeutically classified) in the country. and
the role of the ecological factors on the chemical constituents of the
same plant available in various tropical Zones of the country. This
facilitates to select a plant for collection of the herbal medicines
suitable to be used for the therapeutic usage for a medicinal
professional or an herbal trader. [0567] 6. Analysis of the fingerprints
using this software gives role of ecological factors on various herbal
medicines available in the country and it is useful for Quality Control,
Forensic and Customs Departments to control use and misuse of the herbal
medicines at the national interest [0568] 7. The analysis of the
fingerprints is useful to understand the therapeutic efficacy of the
medicines using the physico-chemical properties of the medicines as
reported in the ancient literature. [0569] 8. The analysis also gives
information about the medicinal value of the various medicinal plants in
the country and the role of the ecological factors on the chemical
ingredients of the same medicine available in various parts of the
country. [0570] 9. The therapeutic and ethano-botanical classification
of the fingerprints helps to bring some generalizations useful for the
doctors and researchers for a complete understanding of the traditional
medicines by analyzing the fingerprints. [0571] 10. By bar coding the
image properties the medicines/
plant extracts/plants are saved from
piracy as the facility to create a barcode using the properties of the
image through note pad facility. [0572] 11. The barcodes are utilized in
all commercial transactions of modern ERP and CRM applications.
Application Utilities of the Present Invention International
[0573] It is useful for any country for fingerprinting and patenting the
traditional medicines of that country. Because the finger print of a
single medicinal plant is not similar to a finger print of the same plant
in another place or country due to the variations in its chemical
profile. The variations in chemical profile is due to the influence of
Ecological factors like the tropical region variations, soil, water
quality and the genotypic and phenotypic variations factors on the
chemistry of the plant.
[0574] This method helps the country to fulfill one of the regulations
made by WHO, for the member countries to standardize methods for the
utility and quality control of herbal medicines and their regulation.
National
[0575] This is useful as a tool to prevent international piracy of
traditional medicines by Passing a Law that the "The Medicinal plants for
which the finger prints are developed are national property". If a
medicine is applied for any type of patent, in any place of the world and
if the finger print, tallies with the finger print of the medicine
available in the challenging country, the patent could be objected.
Strategic
[0576] Bar coding the fingerprints of the medicines helps in the authentic
regulation and protection of the medicinal plants.
[0577] By converting the barcode of the fingerprint of a medicinal plant
into a machine-readable language, commercial and regulatory work becomes
easy.
[0578] Fingerprints of the medicines helps the Food and Drug controllers,
Customs and Central Excise departments to regulate, check the use, misuse
and pilferage of the herbal medicines inside the country and while
allowing importing of such medicines.
Industrial
[0579] A fingerprint developed for a medicine or a formulation helps the
industry to protect their process technology by comparing the fingerprint
of the same medicine of other brands. Thus, it helps to implement the
patent law more efficiently.
[0580] The fingerprint helps to monitor how the medicines are changing its
medicinal properties by the addition of another medicine at different
stages of process of preparing a formulation.
[0581] Industry can use the database of fingerprints developed for all the
native plants available in the country, for their selection of the place
of collection of a medicine. It helps the industry, which part of the
country, and in which season is suitable for the collection of herbal
medicines, as the ecological factor changes the therapeutic efficacy of
the medicines.
Scientific
[0582] This method helps the researchers to understand the traditional
formulations prepared. It also helps to monitor a new formulation under
preparation.
[0583] It helps to know how new molecules are formed when a complicated
traditional formulation is prepared.
[0584] The fingerprints developed for a same medicine extracted under
different pH value helps to understand the drug release in the intestine
system at different pH values of an individual.
[0585] The contour chromratogram of the medicine becomes a Fingerprint of
it. Because it contains the UV-Vis spectrum band with concentration of
the ingredients along with the polarity of the molecule.
[0586] The spectral bands of all the constituents are given in a single
picture, assess the medicine about its therapeutic properties and nature,
very easily.
[0587] The 3-D Chromatogram becomes a photo of all the UV-spectra of all
wavelengths of each constituent in a single picture indicating the
chemical (conjugative and polarity) property of the molecule eluted
[0588] The database also gives information about the medicinal value of
the various medicinal plants of the country (therapeutically classified)
in the country and the role of the ecological factors on the chemical
constituents of the same plant available in various tropical Zones of the
country. This facilitates to select a plant for collection of the herbal
medicines suitable to be used for the therapeutic usage for a medical
professional or an herbal trader.
[0589] The therapeutic and ethano-botanical classification of the
fingerprints helps to bring some generalizations useful for the doctors
and researchers for complete understanding of the traditional medicines
by analyzing the fingerprints.
[0590] The present method facilitates to prepare chromatographic finger
printing of herbal medicines and formulations, which is useful for many
quality control and regulation purposes.
[0591] The present method facilitates chemical standardization,
(qualitative and quantitative) of the said medicines by providing the
conjugative and polarity properties of the individual molecules present
in the medicines or any organic or organo-metallic compound which has
UV-VIS absorptive property. This kind of analysis is of much use in the
chromatographic analysis of Herbal medicines of Single and Formulations,
where the use of external or internal standards are practically not
possible.
[0592] The invention facilitates to study, understand and monitor the
therapeutic efficacy of the said medicine under study. It helps to
understand the therapeutic actions and properties of traditional
medicines reported in the ancient literature and confirm the same in the
form of a reproducible analytical data. Thus, it provides therapeutic
standardization of the medicines under study. It shows the polarity zones
like Polar, Medium polar and Non polar molecules present in the sample,
thus facilitating to understand the efficacy of the medicine as a whole.
[0593] This method facilitates to re-standardize the reported medicines to
the present therapeutic needs. It helps to monitor and study formation of
new organic and organo-metallic molecules, which has UV-VIS absorptive
property, in the process of preparing a reported or a new formulation.
This also helps to standardize the process technology of preparing a
reported or new formulation by monitoring the constituents and their
changing chemical and therapeutic properties.
[0594] It facilitates to generate a barcode by an in built bar coding
software, wherein the X retention time, Y wavelength, R number of red
pixels, G number of green pixels and B number of blue pixels are the
coordinates given by the present software. Some examples of the barcode
for chromatograms are given. The invention also facilitates bar coding
one or more of the constituents present in the fingerprint thus
facilitating the commercial transactions easy by ENTERPRISE RESOURCE
PLANNING (ERP) and CUSTOMER RELATIONSHIP MANAGEMENT (CRM) applications. A
database thus prepared helps the regulatory authorities to monitor the
movement of the said medicines inside or from outside the country, from
production to the consumer. The database of the barcodes thus prepared,
becomes the resource for the ERP vending machines or of any of such kind.
The machine will display all details of the medicines like company, its
chemical fingerprint, and the therapeutic efficacy of the medicines the
said medicine. This makes the identification of the medicines more
authentic than the present.
[0595] A data base of the fingerprints thus generated using this method
helps to bring many generalizations of the therapeutic efficacy of a
particular therapeutic class of plants. Thus, one can under stand why a
particular plant is added in that class. This is explained in the Table
14 enclosed.
[0596] The fingerprints printed on the label of the medicine helps the
doctors to understand the therapeutic efficacy of the medicine just
before use and confirm the quality control of the medicines for every
batch.
[0597] The Image analysis of Chromatographic Finger Print Images (Contour
Chromatograms) of various Medicines of any philosophies (Single and
Formulations) developed, are useful for many purposes as described in
various steps of this application.
Social
[0598] This is useful to know for a consumer, the therapeutic efficacy of
medicines single or formulated claimed on the label and confirms to
contain the same.
[0599] This helps the consumer-act to monitor the quality control of
herbal medicines sold in the market and protect the interests of the
consumer.
Adulteration
[0600] The Image analysis of Chromatographic Finger Print Images (Contour
Chromatbgrams) of various Medicines of any philosophies (Single and
Formulations) developed is useful for detection of any adulteration of
the medicines.
TABLE-US-00002
TABLE 1
Table of Different Philosophies And Various Terminology Used in Medicine
Sl TRI PANCHA SAPTA TRI
No PHILOSOPHY DOSHA (Hara) BHUTA PROPERTIES DHATU MALAS
1 Ayurveda Vata, 1. Prithivi 1. Rasa-Taste-6 1. Rasa 1. Purisha
(Shown elaborately Pitta, 2. Ap 2. Guna-Property-Basically 20 2. Rakta 2.
Mutra
in seperate table) Kapha. 3. Teja 3. Veerya-Potency-2 3. Mamsa 3. Sweda
Binary: 4. Vayu 4. Vipaka-Metabolite-3 4. Medas
Prakriti-Purusha 5. Akasha 5. Prabhava-Specific properties- 5. Asthi
Innumerable 6. Majja
6. karma-Action 7. Shukra
2 Siddha Pitta, 1. Mann(Prithivi) 1. Rasam 1. Rattam (Blood) 1. Malam
Binary: Kapha, 2. Neer (Ap) 2. Gunam 2. Sadhai (Muscle) 2. Mutram
Prakriti-Purusha Vata 3. Thee (Agni) 3. Veeryam 3. Kozhuppu (Medas) 3.
Vervai
4. Vayu (Vayu) 4. Vipakam 4. Elumbu (Bone)
5. Akasa (Akasha) 5. Vindhu, Karu (Sperm, Ovum)
3 Chinese 1. Yang 1. Wood 1. Sour 1. Sinuses Information
Binary: Yin-Yang 2. Yin 2. Fire 2. Bitter 2. Blood vessels not
3. Earth 3. Sweet 3. Muscles available*
4. Metal 4. Shark 4. hair
5. Water 5. Salty 5. Bones
4 Tibetan Nes Pas 1. Sa (Prithvi) Information not available* Lus Zuns Bdun
Dri Ma
1. Mkhris (Pitta) 2. Chu (Ala) 1. Dans Ma (Rasa) 1. Bsan
2. Bad-Kan (Kapha) 3. Me (Agni) 2. Khrg (Rakta) 2. Gcin
3. Rlun (Vata, 4. Rluin (Vayu) 3. Sa (Mamsa) 3. Rnul
Vayu) 4. Tsil (Medas)
5. Rvs (Asthi)
6. Rkan (Majja)
7. Khu Ba (Shukra)
5 Unani Akhalat Arkan 1. Garm (Hot) 1Primary: Blood, Phlegm, Bile, 1. Bole
Binary: 1. Damvi (Blood) 1. Aag (Fire) 2. Khush (Dry) Saudai 2. Baraj
Normal-Abnormal 2. Balgam (Phlegm) 2. Hawa (Air) 3. Sard (Cold)
Secondary: 3. Paseena
3. Safravi (Bile) 3. Pani (Warter) 4. Motadil (Neutral) 1.
Mahsoora(Intravascular)
4. Saudai (Vata) 4. Earth (Mitti) 2. Talliya (Pericellular)
3. Qureeba (Intercellular)
4. Munviya (Cellular)
Body organs Simple, Compound
6 Greek 1. Yellow Bile 1. Water 1. Hot 1. Unctuous
Contrary medicine 2. Black Bile 2. Earth 2. Dry 2. Rough
3. Phlegm 3. Fire 3. Wet 3. Hot
4. Blood 4. Air 4. Cold 4. Cold
[0601]
TABLE-US-00003
TABLE 2
Relation Of Humors, Properties, And Different Parts Of The Human Body - An
Ayurvedic Approach Approach
RELATION
PANCHA EFFECT ON ON
BHUTA DOSHAS VIPAKA
(PHYSI- (DECREASING (POST
TRI CAL MAHABHUTA THE DOSHA) ASSIM-
Sl. DOSHA TRI PROPER- SAPTA CHEMICAL RELATIONS DUE TO ILATIVE
No (Hara) MALAS TIES) DHATUS PROPERTIES WITH DHATUS DHATUS RELATION ON
GUNA EFFECT)
1. Vata, 1. Purisha 1. Prithivi 1. Rasa 1. Rasa a. Prithivi + Ap a. Pitta
Vata Hara a. Guru, Sheeta, snigdha a. Madhura
2. Pitta, 2. Mutra 2. Ap 2. Rakta (Shadruchi's) b. Agni + Prithive b. Vata
Hara b. Ushna, Laghu, snigdha b. Amla
3. Kapha 3. Sweda 3. Teja 3. Mamsa a. Madhura c. Jala + Agni c. Vata Hara
c. Ushna, Laghu, Snigdha c. Madhura
4. Vayu 4. Medas b. Amla d. Aksha + Vayu d. Kapha Hara d. Ushna, Laghu,
Ruksha d. Katu
5. Akasha 5. Asthi c. Lavana Eagni + Vayu e. Kapha Pitta e. Sheeta,
Laghu, Ruksha c. Katu
6. Majja d. Katu f. Prithive + Vayu Hara f. Sheeta, Guru, Ruksha f.
Katu
7. Shukra e. Tikta f. Kapha Pitta
f. Kashaya Hara
2. Guna-:
Broadly
classified into 3
groups
1. Vaisheshik
2. Samanya
3. Atma
Mostly
used are:
Guru (Heavy)
Laghu (Light)
Sheeta (Cold)
Ushna (Hot)
Snigdha (Soft,
Lubricated,
Supple)
Rooksha (Dry)
Manda (Slow)
Teekshna
(Sharp)
3. Veerya-2
4. Vipaka-3
5. Prabhava-
innumerable
The properties of the materials and disease were correlated to select a
medicine - The therapeutic standardization
[0602]
TABLE-US-00004
TABLE 3
Table Showing Division in terms of the Macrocosm in Chinese medicine
Sl After
No. Elements Seasons Color Taste influence Development
1 Wood Spring Blue Sour Wind Birth
2 Fire Summer Red Bitter Heat Growth
3 Earth Late Yellow Sweet Humidity Puberty
Summer
4 Metal Autumn White Shark Drought Maturity
5 Water Winter Black Salty Cold Senility
Basis of color for therapeutic standardization
[0603]
TABLE-US-00005
TABLE 4
Table Showing Division In Terms Of the Microcosm in Chinese Medicine
SL Sense Structural
No. Elements organs Fus Tsangs Emotional eluents
1 Wood Eye Bile Liver Anger Sinuses
2 Fire Tongue Small Heart Joy Blood
intestine Vessels
3 Earth Mouth Stomach Spleen Anxity Muscle
4 Metal Nose Large Lung Sadness Hair
intestine
5 Water Ear Bladder Kidne Fear Bones
[0604]
TABLE-US-00006
TABLE 5
Table Showing the Relation of Five Natural Elements and Their Relation, in
Chinese Medicine
Element Element Yin & Yang
1.sup.st Heaven engendered Water 2.sup.nd Energy engendered Fire
corresponds to the Heart & Small intestine
3.sup.rd Heaven engendered Wood 4.sup.th Energy engendered Metal
corresponds to the Lung & Large intestine
5.sup.th Heaven engendered Earth 6.sup.th Energy completed Water
corresponds to the Kidney & Bladder
7.sup.th Heaven completed Fire 8.sup.th Energy completed Wood corresponds
to the Liver & Gall bladder
9.sup.th Heaven completed Metal 10.sup.th Energy completed Earth
corresponds to the Spleen & Stomach
[0605]
TABLE-US-00007
TABLE 6
Table Showing the Meaning of Yin and Yang Used In Chinese Medicine
Yin Yang
(The shady side of the hill) (The sunny side of the hill)
Light Dark
Night Day
Damp Dry
Cold Hot
Water Fire
Evil Good
Ugly Beautiful
Vice Virtue
Poverty Healthy
Sadness Joy
Confusion Order
Punishment Reward
Disease Health
Positive Negative
Female Male
Bad Good
Wife Husband
[0606]
TABLE-US-00008
TABLE 7
Table Showing The Basis Of Color For The Therapeutic Standardization Of
Medicines
Color White Color Medicines Yellow Color Medicines Red Color Medicines
Black Color Medicines
Name in Sancrit Shukla Varga Peeta Varga Rakta varga Krishna Varga
Sloka
Name of the Sudha Chuna (Lime) Kusumba Pushpa Dadima(Punica granatum)
Kadali (Musa paradisiaca)
medicines/ Kachhapa Prista (Shell of Kimshuka (Butea Palasha(Butea
monosperma) Karavellika(Momordia charantia)
materials tortoise) monosperma) Laksha(Laccifera lacca) Triphala(Three
myribalans)
Shankha (Conch) Haridra (Curcuma longa) Bandhuka Neelika (Indigofera
Tinctoria)
Shukti (Shell of Pearl) Patanga (Caesalpinia sappan) Haridra (Curcuma
longa) Nala (Cymbophogan species)
Varatika (Small shells) Madayantika(Lasonia Kusumba Pushpa Panka (Lotus)
Brushtashma (Incinerated Stone) Inermis) Manjista (Rubia cordifolia)
Kaseesa(Fe.sub.2S.sub.3)
Sarkara (Sugar candy) *Rasamava *Rajanighantu Balamra (Unripen Mango)
*Rajanighantu by Vaidya *Rasendra Chudamani
Narahari
The names of the medicines were given as sloka
[0607]
TABLE-US-00009
TABLE 8
The Effect Of Different Colors On Different Diseases
Cool effect Neutral Creat heat
Violet Indigo Blue Green Yellow Orange Red
1. Bones & 1. E-N-T problems 1. Whooping cough, 1. Heart problems 1. All
disorders 1. Long term 1. Anaemia
Bone marrow, 2. Facial paralysis 2. Throat problems, 2. Low and high of
digestion Asthma 2. Disability
2. Tumour, 3. Diseases of the lungs, 3. Fever, B. P 2. Spleen, liver 2.
bronchitis 3. Sluggishness
3. Baldness, 4. Asthma, 4. Typhoid, 3. Skin problems problems 3. Swelling
in 4. Cold
4. Cataract, 5. T. B, 5. Small-pox, 4. Cancer 3. Diabetis trachea 5.
Paralysis
5. Blindness 6. Less digestive power, 6. Measles, 5. Influenza 4. Leprosy
etc., 4. Gout 6. White spots
7. Problems of nervous 7. Ulcers in mouth 6. Syphilis 5. Swelling 7.
Arthrites
systems, 8. Cholera 7. pain in the eyes 6. Kidney 8. T. B etc.,
8. Convulsion, 9. Swelling in the etc., 7. Mental
9. Lunacy brain nervousness
10. Problems of 8. Epilepsy
nerves etc.,
11. Insomnia,
12. Mental
depression
13. Problems of
semen discharge
14. Burns,
Bleeding from nose
etc.,
The role of colors and their influence on different body parts, The basis
of color is used for selecting a medicine. For eg. A plant with Indigo
flowers will cure ENT problems
[0608]
TABLE-US-00010
TABLE 9
Properties of the SIX Tastes (Rasas in Ayurveda) and their properties and
efficacy
Predominent Examples
Taste element Effects on Dosha Dietary Item Drug
Sweet (Madhur) Earth + Water Kapha .uparw. Sugar, Banana, Jack fruit,
Glycerrhiza Glabra.,
Vata and Pitta .dwnarw. Raisins, Milk, Coconuts, Asparagus Racemoses,
Jaggary Gold
Sour (Amla) Earth + Fire Pitta and Kapha .uparw. Tamarind, Buttermilk,
Curds, Embalika officinalis
Vata .dwnarw. Raw mango
Salty (Lavana) Water + Fire Pitta and Kapha .uparw. Salt Rock salt
Vata .dwnarw.
Pungent (Katu) Air + Fire Pitta and Vata .uparw. Asoefetida, Pepper,
Chilli, Dry Piper longum
Kapha .dwnarw. processed Zinger
Bitter (Tikta) Space + Wind Vata .uparw. Bitter gourd Azadiracta indica,
Pitta and Kapha .dwnarw. Swertia chiraita,
Tinospora Cordifolia
Astringent (Kashaya) Wind + Earth Vata .uparw. Honey Terminalia chebula,
Pitta and Kapha .dwnarw. Treminalia Bellerica,
Pearls,
Corals
This table shows how tastes and medicines are related to vitiation of
diseases.
[0609]
TABLE-US-00011
TABLE 10
Table or Colors and The Relation with Wavelengths.
Wavelength Color Color observed (Transmitted)
Nm (Absorbed from white light) or Complementary Hue*
<380 Ultraviolet Yellowish green
380-435 Violet Yellow
435-480 Blue Orange
480-490 Greenish blue Red
490-560 Bluish green Purple
500-560 Green Violet
560-580 Yellowish green Blue
580-595 Yellow Greenish blue
595-650 Orange Bluish green
650-780 Red
>780 Near - Infra red
*The constituents having these colors will absorb at the respective
wavelengths given The materials or medicines will show colors based on
the absorption of a particular color from the range of colors in the
white light falling on them. They will express the resultant color after
absorption.
[0610]
TABLE-US-00012
TABLE 12
Comparison table of existing techniques
Sl
No Reported Technique Method Merits Demerits
1. TLC Fingure Printing 1. Simple, 1. Inferior compared to Closed
chromatography
Open 2. Less time consuming, 2. Incomplete Separations leading to
ambiguous
Chromatography 3. Less operational Costs separations
3. Unreliable fingure printing due to influence of
variations in analytical conditions
4. Needs the support of other costlier analytical
instruments like LC-MS, NMR and IR with out
which the data is incomplete.
2. HPTLC Fingure Printing 1. Simple 1. Inferior compared to Closed
chromatography.
Open 2. Less time consuming 2. Incomplete Separations leading to
ambiguous
Chromatography 3. Less operational Costs separations.
3. Unreliable fingure printing due to influence of
variations in analytical conditions.
4. Needs the support of other costilier analytical
instruments like LC-MS, NMR and IR with out
which the data is incomplete.
5. High instrumental cost
3. HPLC 1. Chromatogram 1. Better separations 1. Needs the support of
other costilier analytical
Closed at a specified 2. facility to change the instruments like LC-MS,
NMR and IR with out
Chromatography wave length polarity of the mobile phase to which the data
is incomplete.
(Superior than open elute all molecules of entire 2. High instrumental
cost
chromatography) range of polarity. 3. High operational cost
4. PROPOSED 1. Chromatogram 1. Better separations 1. High instrumental
cost
METHOD indicates the 2. facility to change the (almost equal or less than
a HPTLC instrument)
HPLC entire range of polarity of the mobile phase to 2. High operational
cost
Closed wave length. elute all molecules of entire
Chromatography 2. Utilisation of range of polarity. OPERATIONAL
LIMITATIONS OF THE
(Superior than open CONTOUR 3. Facility to measure the PRESENT COMPUTER
BASED METHOD
chromatography) CHROMATOGRAMS absorbance of the molecules at 1. This
computer based method works only for
for the various wave lengths of the contour chromatograms with out
scale.
analysis of the entire range of 200-800 nm. 2. The Image developed has
to be resized using
organic and This Will not leave any imaging software to match the run
time and
Organo-metallic molecule UNSEEN or wavelength range on X and Y-axis.
molecules 3. UNIDENTIFIED. 3. The images after analysis will be saved
only in
Utilisation of 3-D 4. Facilitates to prepare the JPEG format with out
scale which occupies less
CHROMATOGRAMS "Chromatographic Finger memory of the system.
for the Prints" of the native medicinal 4. The clip images should be
stored with an
analysis of the plants of a country as extension of the co-ordinates
ie., X1 and Y2.
organic and suggested by WHO. How ever they can be eliminated by the
addition
Organo-metallic 5. Facilitates to understand the of more software
features
molecules therapeutic efficacy of the
medicines by studying the
conjugative and polarity
properties of the constituents
separated by this method.
6. Facilitates to understand the
therapeutic efficacy of a
particular therapeutic class of
plant (just like the method
used in the identification of the
personality of a culprit, as used
in the FINGER PRINT SOFTWARE
used by the Forensic
departments.
[0611]
TABLE-US-00013
TABLE 13
PARAMETERS USED FOR FINGER PRINTING OF MEDICINES
3-D PARAMETERS*
FIG BOTANICAL NAME OF VERNACULAR ELEVATION ROTATION
NO. THE PLANT NAME PART USED DEGREES DEGREES
29 ABEL MOSCHUS KASTURI BENDA WHOLE PLANT 20 15
MOSCHATUS MEDICUM
30 ACACIA SUMA SWETHAKHADIRA BARK 15 65
31 ACALYPHA INDICA KUPPINTA LEAF LETS 10 60
32 ADHATODA VASAKA VASA LEAVES 25 45
33 ADIANTUM CAUDATUM MAYURASHIKHI LEAVES 20 40
34 AILANTHUS EXCELSA ARALU STEM BARK 10 65
35 ACORUS CALAMUS VACHA RHIZOME 10 130
36 ALLIUM PORUM MAHALASUNA LASSAN, BIG 20 130
SINGLE
CLOVES
37 ALLIUM SATIVAM LASUNA LASSAN, 20 130
SMALL
CLOVES
38 ALPINIA GALANGA GREATER RHIZOME 20 75
GALANGA.
39 ALPINIA OFFICINARUM LESSER GALANGA RHIZOME 15 75
40 ALPINIA SPECIOSA LIGHTER RHIZOME 10 60
GALANGA
41 ARECA CATECHU BEETLE NUT UN PROCESSED 15 40
FRUIT NUT
42 ARECA CATECHU BEETLE NUT MILK 15 40
PROCESSED
NUTS
43 ARECA KATEEH RAKTHA STEM BARK 15 65
KHADIRA
44 ARNICA ARNICA MOTHER 10 55
TINCTURE OF
WHOLE PLANT
45 BACOPA MONNERI BRAHMI WHOLE HERB 15 45
46 BERBERIS ARISTATA DARUHARIDRA STEM AND 15 170
BARK
47 BORRHIEVIA DIFFUSA PUNARNAVA WHOLE PLANT 15 55
48 CAPSCICUM ANNUM L MIRCH BIG, RIPED 10 70
FRUIT
49 CAPSCICUM ANNUM L MIRCH BIG UNRIPED 10 70
FRUIT
50 CAPSCICUM ANNUM L MIRCH SMALL, 10 70
UNRIPED,
FRUIT
51 COSCINIUM LATA DARVI STEM BARK 15 125
FENESTRATIUM
52 COCCINIDIUM GRANDIS DONDA ROOT AND 25 30
LEAF
53 DACTLYLACTINIUM GRASS LEAF 25 40
AEGYPTIUM(ERECT)
54 DACTLYLACTINIUM GRASS LEAF 25 40
AEGYPTIUM(PROSTRATE)
55 DIRISTACHIS TUMMA LEAF AND 20 15
CINERARIA BARK
56 EMBLICA OFFICINALIS AMALAKI FRUIT EPICARP 5 50
57 FACE PACK BRAND 1 FORMULATION 20 25
58 FACE PACK BRAND 2 FORMULATION 20 25
59 GLYCERRHZIA GLABRA YASHTI MADHU ROOT BARK 15 130
60 GLYCERRHZIA GLABRA YASHTI MADHU POWDER OF 15 130
WHOLE PALNT
61 GYMNEMA PODAPATRI WHOLE PLANT 25 15
SYLVESTRAE
62 HOLLERONA KUTAJA STEM BARK 10 60
ANTIDYSENTRICA
63 INNULA RECEMOSA PUSHKARAMULA ROOT 5 45
64 MICHELLIA CHAMPAKA MANU SAMPENGA FLOWER 20 40
65 MORINGA OLIFERA MUNAGA LEAF 25 40
66 MYRICA CEREFERA BAY BERRY MOMEOPATHIC 20 35
MOTHER
TINCTURE
67 NAHI AXILLAE NAHI WHOLE PLANT 10 130
68 OROXYLUM INDICUM SYONAKA STEM BARK 10 170
69 OCIMUM SANCTUM RAMA TULASI LEAF 15 130
70 PLUCHEA PATRA RASNA LEAF 10 65
LANCEOLATA
71 PICRORRHIZA KURROH KATUKI ROHINI STEM BARK 15 125
72 PIPER BEETLE BEETLE LEAF 25 160
73 PSORALIA CORILIFOLIA BAKUCHI SEEDS 25 60
74 RAPHANUS SATIVUS MULLANGI, WHITE LEAF 15 25
75 RICINUS CUMMUNIS ERANDA MULA ROOT 10 135
76 RUBIA CORDIFOLIA MANJISTA STEM AND 10 40
ROOT
77 SAUSSREA LAPPA KUSHTA ROOT 5 80
78 SPHERANTHUS INDICUS MUNDI WHOLE HERB 15 70
79 SYMPLOCUS LODHRA STEM BARK 15 65
RACEMOSUS
80 TERMINALIA CHEBULA HARITAKI FRUIT 10 40
81 TERMINALIA VIBHITAKI FRUIT 20 35
BELLERICA
82 TRIGONELLA FAENUMG. MENTHI WHOLE PLANT 15 160
83 TRIBULUS GOSHURA STEM AND 25 45
TERRESTRIAS ROOT
84 TYLOPHORA LEAVES 10 65
ASTHMATICA
85 VIBURNUM MOTHER MOTHER 20 15
TINCTURE TINCTURE OF
HOMOEO
MEDICINE
86 WITHINIA SOMNIFERA ASWAGANDHA ROOT 5 50
87 ZINZIBER OFFICINALIS SHUNTI PROCESSED 15 130
ZINGER,
RHIZOME
88 AVIPATTAKARA AYURVEDA POWDER 25 60
CHURNA FORMULATION
89 KAMADUGA SIDDHA POWDER 10 25
FORMULATION
90 KUMARAYASAVA AYURVEDIC LIQUID 10 35
MEDDICINE BY
FERMENTATION
PROCESS
91 MAHALAKSHMI VILAS SIDDHA POWDER 20 35
RAS FORMULATION
92 SUVARNA YOGARAJA SIDDHA POWDER 10 40
GUGGULU FORMULATION
ALL THE OTHER PARAMETERS OF RANGE OF WAVE LENGTH, ABSORBANCE SCALE AND
RETENTION TIMES ARE SHOWN IN INDIVIDUAL FIGURE
[0612]
TABLE-US-00014
TABLE 14
MEDICINES USED FOR FINGER PRINTING
DOSHA HARA
(Disorder on which
PACIFIES)
BOTANICAL NAME OF THE PLANT VERNACULAR NAME EFFICACY* PITTA KAPHA VATA
PART USED
PITTA HARA
AVIPATTAKARA AYURVEDA Laxative, .dwnarw. POWDER
CHURNA FORMULATION Peptic ulcer,
Piles
ACALIPHA INDICA HARITA Hepatoprotectitive, .dwnarw. LEAF
MANJARI Skin diseases,
Gyneac disorders
ANANDABHAIRAVI HERBOMINERAL Pitta jwara FORMULATION
AROGYA VARDHINI HERBOMINERAL Liver disorders, .dwnarw. FORMULATION
Skin disorders
BHUMYAMALAKI PHYLLANTHUS Jaundice .dwnarw. WHOLE HERB
URINARIA
KAMADUGA FORMULATION Peptic ulcer .dwnarw. FORMULATION
KUMARAYASAVA FERMENTATION Gyenic disorders, .dwnarw. LIQUID
PROCESS Jaundice
SARACA INDICA ASHOKA Gyeneac disorders .dwnarw. STEM BARK
SURYAVARTI HERBOMINERAL Head ache .dwnarw. FORMULATION
KAPHA HARA
AILANTHUS EXCELSA ARALU Digestive disorders .dwnarw.
ASPARAGUS SAFED MUSALI Aphrodisiac, .dwnarw. ROOT
ADESCENDENTUM impotency
ADHATODA VASICA VASA Respiratory .dwnarw. ROOT
disorders
ADIANTUM CAUDATUM MAYURASHIKHI Piles .dwnarw. WHOLE HERB
Cough
Diarrhoea
ALLIUM SATIVAM LASUNA Swasa .dwnarw. SMALL CLOVES
ALLIUM PORUM MAHALASUNA Swasa .dwnarw. BIG SINGLE
CLOVE
ACACIA SUMA SWETHA Diabetis .dwnarw. STEM BARK
KHADIRA
CAPSCICUM ANNUM L KATUVEERA Digestive disorders .dwnarw. BIG
UNRIPED, FRUIT
COCCINIDIUM GRANDIS BIMBI Emitic .dwnarw.
CHOPACHINYADI HERBAL Venerial, .dwnarw. POWDER
CHURNAM FORMULATION Skin diseases
GLYCERRHZIA GLABRA YASHTI MADHU Panduroga, .dwnarw. ROOT, BARK
Rasayana
HIBISCUS ABEL LATA KASTURI Siheshma roga, .dwnarw. WHOLE PLANT
MOSCHUS Prameha, urinary WITH FLOWERS
blader &kidney AND SEEDS
disorders
INNULA RECEMOSA PUSHKARAMULA Kasa, swasa, jaundice, .dwnarw. ROOT
diabetis
KRIMIKUTARA RAS HERBO-MINERAL Worm infestation .dwnarw. FORMULATION
OCIMUM SANCTUM RAMA TULASI Cough, .dwnarw. LEAF
Fever
RAPHANUS SATIVUS MULKA, WHITE Diabetics, cough, g. .dwnarw. LEAF
i.tract
disorders, neutraceuticals
SAUSSREA LAPPA KUSHTA Respiratory .dwnarw. ROOT
disorders
SHILAJIT (H) HERBOMINERAL Diabetis, .dwnarw. BITUMINOUS
Renal stones
SHILAJIT (G) HERBOMINERAL Diabetis, .dwnarw. BITUMINOUS
Renal stones
TYLOPHORA AJADWESHI Asthama LEAF
ASTHAMATICA
VATA HARA
ALPINIA GALANGA GREATER Rheumatic .dwnarw. RHIZOME
GALANGA, disorders
ALPINIA LESSER Rheumatic .dwnarw. RHIZOME
OFFICINARUM GALANGA disorders
ALPINIA SPECIOSA LIGHTER Rheumatic .dwnarw. RHIZOME
GALANGA disorders
BRIHATVATACHINTAMANI + HERBO-MINERAL Arthritis .dwnarw. FORMULATION
SWARNAMAKSHKAM
BORRHIEVIA PUNARNAVA Odema, .dwnarw. WHOLE PLANT
DIFFUSA Urinary tract,
diuretic disorders
HUTHASANA HERBO-MINERAL All types of fevers .dwnarw. FORMULATION
MAHAYOGARAJA HERBAL Arthrites .dwnarw. FORMULATION
GUGGULU
PLUCHEA PATRA RASNA Rheumatic .dwnarw. LEAF
LANCEOLATA disorders
RICINUS COMMUNIS ERANDA MULA Constipation, .dwnarw. ROOT
Rheumatoid disorders
SUVARNA YOGARAJA SIDDHA Rheumatic diseases .dwnarw. POWDER
GUGGULU FORMULATION
SHITAMSU RAS HERBO-MINERAL Jwara .dwnarw. FORMULATION
SUVARNA YOGARAJA HERBAL Arthrites .dwnarw. FORMULATION
GUGGULU FORMULATION
VATA GAJANKUSA RAS HERBO-MINERAL Sciatica .dwnarw. FORMULATION
PITTA KAPHA HARA
ACACIA CATECHU RAKTHA Skin diseases diabetis .dwnarw. .dwnarw. STEM BARK,
KHADIRA EXUDATE
AILANTHUS EXCELSA ARALU Digestive disorders .dwnarw. .dwnarw. BARK
ARECA CATECHU KRAMUKA Diabetis, .dwnarw. .dwnarw. MILK PROCESSED
Skin disorders NUT
AZARIDICTA INDICA NIMBA Skin diseases, .dwnarw. .dwnarw. TENDER LEAVES
Infective conditions
BERBERIS ARISTATA DARUHARIDRA Obesity .dwnarw. .dwnarw. ROOT BARK
Skin disorders
CITRULLUS INDRAVARUNI Purgative, juandice, .dwnarw. .dwnarw. HOMOEO
MOTHER
COLOSYNTHIS aborttificient TINCTURE
CURCUMA LONGA TURMERIC Worm infestation, .dwnarw. .dwnarw. COMMERCIAL
dysentry, diarrhoea, skin POWDER-1
disorders, wounds
CURCUMA LONGA TURMERIC Worm infestation, .dwnarw. .dwnarw. COMMERCIAL
dysentry, diarrhoea, skin POWDER-2
disorders, wounds
CURCUMA LONGA TURMERIC Worm infestation .dwnarw. .dwnarw. COMMERCIAL
dysentry, diarrhoea, skin POWDER-3
disorders
Wounds
COSCINIUM LATA DARVI Diabetis .dwnarw. .dwnarw. STEM
FENESTRATIUM Obesity,
Skin disorders
CURCUMA LONGA HARIDRA Skin, .dwnarw. .dwnarw. RAW RHIZOME
Allegic,
Diabetic
DACTYLACTINIUM GRASS Diuretic, improves .dwnarw. .dwnarw. WHOLE PLANT
AEGIPTIUM complexion LEAVES
(PROSTRATE AND
ERECT)
EUGENIA JAMBU Vomiting, diabetic, .dwnarw. .dwnarw. FRUIT
JAMBOLONA Dysentry
SIZYGIUM CUMINI
HOLLERNA KUTAJA Diarrhoea, .dwnarw. .dwnarw. STEM BARK
ANTIDYSENTRICA Haemorroids FROM ANDHRA
PREADESH
HOLLERNA KUTAJA Diarrhoea, .dwnarw. .dwnarw. STEM BARK
ANTIDYSENTRICA All gi tract disorders FROM KERALA
RUBIA CORDIFOLIA MANJISTA Skin disorders .dwnarw. .dwnarw. STEM, ROOT
Leukemia
Blood purifier
PSORALIACORYLIFOLIA BAKUCHI Leucoderma, .dwnarw. .dwnarw. SEEDS, SEED OIL
Skin diseases
PICRORRHIZA KATUKA Laxative .dwnarw. .dwnarw. ROOT
KURROA ROHINI Liver disorders
TRIGONELLA METHIKA Diabetis, colic .dwnarw. .dwnarw. WHOLE HERB
FENUM G.
SYMPLOCOS LODHRA Bleeding .dwnarw. .dwnarw. BARK
RACEMOSA disorders, diarrhoea,
dysentry
SPERANTHUS INDICUS MUNDI Krimihara, .dwnarw. .dwnarw. WHOLE HERB
Migrain, vrishya,
lymphatic disorders
KAPHA VATA HARA
ACORUS CALAMUS VACHA Medhya .dwnarw. .dwnarw. RHIZOME
Speeh disorders
ALOEVERA KUMARI Gyneac disorders, .dwnarw. .dwnarw. LEAF, LEAF JUICE
hepatomegaly, spleeno
megaly, burns, uterine
disorders
AGNITUNDINA HERBAL Indigestion, .uparw. FORMULATION
FORMULATION Skin disorders
MICHELIA CHAMPAKA CHAMPAKA Cosmetic, .dwnarw. .dwnarw. FLOWER
Skin diseases
MORINGA OLEIFERA SIGRU Abcess, oedema .dwnarw. .dwnarw. LEAF
PIPER BEETLE NAGA VALLI Kasa, swasa .uparw. .dwnarw. LEAVES FROM
Digestive disorders COASTAL ANDHRA
PRADESH
PIPER BEETLE NAGA VALLI Kasa, swasa .uparw. .dwnarw. LEAVES
Digestive disorders CULCATTA
TRIKATU CHURNA-1 HERBAL Indigestion .dwnarw. .dwnarw. FORMULATION
FORMULATION
TRIKATU CHURNA SP-2 HERBAL Indigestion .dwnarw. .dwnarw. FORMULATION
FORMULATION
TRIKATU CHURNA GH-3 HERBAL Indigestion .dwnarw. .dwnarw. FORMULATION
FORMULATION
TRIBULUS TERRESTRIAS GOKSHURA Urinary disorders, .dwnarw. .dwnarw. STEM
AND
Oedema ROOT
TYLOPHORA AJADWESHI Diabetis, asthama .dwnarw. .dwnarw. LEAVES
ASTHMATICA
PITTA VATA HARA
ACACIA SUMA SWETHA Prameha .dwnarw. .dwnarw. STEM BARK
KHADIRA
ANANDABHAIRAVI HERBO- .dwnarw. .dwnarw. FORMULATION
MINERAL
BACOPA MONNERI BRAHMI Medhya, skin disorders .uparw. WHOLE HERB
DICROSTACHYS CINERA VEERATARU, Hridya, .dwnarw. .dwnarw. LEAF AND BARK
TUMMA Obescity
ENICOSTEMMA NAHI Malaria .dwnarw. .dwnarw. WHOLE HERB
AXILLAE
KANCHANARA HERBAL Inflammatory conditions .dwnarw. .dwnarw. FORMULATION
GUGGULU FORMULATION
OROXYLUM INDICUM SYONAKA Odema .dwnarw. .dwnarw. STEM BARK
Digestive disorders
TRI DOSHA HARA
ASPARAGUS SWETHA Aphrodisiac .dwnarw. .dwnarw. .dwnarw. ROOT
ABSCENDENSES MUSALI
CAPSCICUM ANNUM L MIRCH, G.I tract disorders .dwnarw. .dwnarw. .dwnarw.
BIG, RIPED FRUIT
KATIVEERA
CURCULIGO KALI MUSALI Aphrodisiac .dwnarw. .dwnarw. .dwnarw. ROOT
ORCHIOIDES
EMBLICA OFFICINALIS AMALAKI Hridya, .dwnarw. .dwnarw. .dwnarw. FRUIT
EPICARP
Rasaya, na
Neutraceutical
KARPURADI RAS HAEMORRHOIDS Diarrhoea .dwnarw. .dwnarw. .dwnarw.
FORMULATION
MAHALAKSHMI VILAS HERBO-MINERAL All types of fevers .dwnarw. .dwnarw.
.dwnarw. FORMULATION
RAS
ONION BIG PALANDU Haemorrhoids .dwnarw. .dwnarw. .dwnarw. BULB
ONION SMALL PALANDU Haemorrhoids .dwnarw. .dwnarw. .dwnarw. BULB
TERMINALIA CHEBULA HARITAKI Laxative .dwnarw. .dwnarw. .dwnarw. FRUIT
Rasayana
TERMINALIA VIBHITAKI Kasa, swasa, .dwnarw. .dwnarw. .dwnarw. FRUIT
BELLERICA Skin diseases, urinary
calliculus
WITHINIA PUB. ASWAGANDHA General debility, .dwnarw. .dwnarw. .dwnarw. ROOT
RED SEEDS rejuvenation
PLANT ROOT
ADULTERATIONS
FACE PACK (G) Good by efficacy FORMULATION
FACE PACK(B) Absence of some FORMULATION
important
constituents like
kushta (sausserea
lappa) and manjista
(rubia cordifolia),
making the
formulation less
effective
HERBAL HEAD BATH No foaming agents found FORMULATION
POWDER (G)
HERBAL HEAD BATH Adulterated with FORMULATION
POWDER (B) foaming agents
HOMOEO MEDICINES
ARNICA Pain reliever, after HOMOEO MOTHER
effects of injury TINCTURE
MYRICA CEREFERA BAY BERRY Hepatoprotective HOMOEO MOTHER
TINCTURE BRAND-1
MYRICA CEREFERA BAY BERRY Hepatoprotective HOMOEO MOTHER
TINCTURE BRAND-2
VIBURNUM MOTHER Gyneacological disorders HOMOEO
TINCTURE MEDICINE
ISOLATED COMPOUNDS
VITEX NEGUNDO SINGLE Hepatoprotective A FLAVONOID
COMPOUND 7-HYDROXY
QUERCETIN
AZAMALYCIN SINGLE SINGLE ISOLATED
COMPOUND COMPOUND
A DIABETIC HERBAL Prameha ADULTERATED WITH
MEDICINE A DIURETIC
ALLOPATHIC AMIDE
CONSTITUENT
BERBERIS ARISTATA SINGLE BERBARIN STD
ISOLATED (FLUKA)
STANDARD
COMPOUND
.dwnarw.: INDICATES DECREASE OF DISORDER
.uparw.: INDICATES INCREASE OF DISORDER
*The therapeutic efficacys reported are as per the information available
with the author, many more may be reported elsewhere.
[0613]
TABLE-US-00015
TABLE 15
Names of the medicines shown as thumbnails of fingerprints
NAME OF THE SAMPLE PART USED
Allopathic medicines
Vitamin-B complex Commercial brand
Analgin Commercial brand
Atenolol Commercial brand
Bromoflexin Commercial brand
Citerizine Commercial brand
Furazolidine Commercial brand
Ibuprofen-Paracetamol Commercial brand
Paracetamol Commercial brand
Herbal Cosmetic samples
Face pack (Poor by efficacy) Commercial brand
Face pack (Good by efficacy) Commercial brand
Head bath powder (Poor by efficacy) Commercial brand
Head bath powder (Good by efficacy) Commercial brand
Herbal Formulations
Agnitundina Commercial brand
Anandabhairavi Commercial brand
Arogyavardhani Commercial brand
Brihatvatachintamani + Commercial brand
Swarnamakshakam
Chopachinyadi Churnam Commercial brand
Commercial Turmeric Brand 1 Commercial brand
Commercial Turmeric Brand 2 Commercial brand
Commercial Turmeric Brand 3 Commercial brand
Huthasana Commercial brand
Homoeo medicines
Arnica Mother Tincture
Calendula Mother Tincture
Colosynthis Mother Tincture
Isolated compounds
7-Hydroxy Quercetin Isolated from Vitex negundo
A flavonoid Isolated from Vitex negundo
Azamalycin Standard
Dexamethasone Standard
Single medicines
Alovera Leaf
Acalypha Indica Leaf
Embalika officinalis Fruit
Aralu Bark
Areca Catachu Seeds
Aswagandha Red fruits Roots
Aswagandha White fruits Roots
Beetle leaf Andhra pradesh Leaf
Beetle leaf Culcutta Leaf
Coscinium Stem Bark
Dactlylactenium aegyptium (Erect) Leaves
Dacylactinium aegyptium (Prostrate) Leaves
Daruharidra Stam Bark
Haridra Raw Rhizome
Kalajamun Fruit
Onion Bulb
Kutaja Stem Bark
Raktakhadira Heart wood
Shilajit Processed Bituminous Source 1
Shilajit Processed Bituminous Source 2
Brahmi Leaf
[0614]
TABLE-US-00016
TABLE 16
The Division of the Fingerprint in to Therapeutic Zone based on the
conjugation and polarity
Based on the color reported, the entire image is divided in to 3 Zones on
X-axis and 3 Zones on Y-axis. X axis shows the POLARITY SCALE due to the
mobile phase composition. Y-axis shows CONJUGATION (due to UV-VIS
absorbance. When the molecule is more conjugated it absorbs at higher
wavelengths (800 nm).
# Thus constituents present in the respective zones will act as shown in
the figure in the respective therapeutic zones will be providing
respective therapeutic efficacy. Quantification of these constituents was
done using the UV-VIS absorptive property which is directly proportional
to the quantity of the constituent.
* * * * *